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I. Abstract 
 
The number of chemicals to which organisms are exposed as a consequence of 
environmental contamination by Industry and Agriculture is increasing. However, there 
is a severe lack of information about the biological effects of many frequently occurring 
chemicals. 
The present thesis is focused on the effects on the thyroid tissue of adult zebra 
fish of the antimicrobial agent Triclosan (TCS) which is frequently found in personnel 
hygiene products and foodstuff. After 21 days exposure of adult zebrafish to TCS 
(100 mg/kg/day) and the thyroid disruptor, Propylthiouracil (PTU, positive control) 
(5 mg/kg/day), histological observation of thyroid tissue in sections of the pharynx was 
performed. These observations indicated significant (p<0.05) increase in follicle areas 
coupled with the decrease of thyrocyte height (thyrocyte inactivation) in TCS treated 
zebrafish. In the PTU treated zebrafish only a reduction in thyrocyte activity was 
observed.  
In order to understand how the test chemical TCS might bring about its effect, 
the gene expression of Thyroglobulin (Tg), Thyroid Peroxidase (TPO), Sodium-Iodine 
Symporter (NIS) and Cathepsin B (CtsB) together with Thyroid Stimulating Hormone 
(TSH) in whole zebrafish head was determined using quantitative real-time Polymerase 
Chain Reaction (qRT-PCR). After sample normalization against the zebrafish 
spermatogenic glyceraldehyde-3-phosphate dehydrogenases (GAPDH-2), validated as 
reference gene for this study, a significant increase (p<0.05) in expression of TSH and 
NIS were detected. The expression of pituitary TSH increased in the PTU and TCS 
groups compared to the control group, while NIS expression only increased in the TCS 
treated zebrafish. For the remaining genes, no significant changes in gene expression 
were detected, maybe as a consequence of high individual variation. 
In summary, the results of the study indicate that the drug TCS at a 
concentration of 100 mg/kg/day for 21 days appears to influence TH synthesis. The 
increase in TSH and NIS transcription coupled to the inactivation of the thyroid tissue 
observed in this work, are indicative of effects caused by a reduction in circulating THs. 
It remains to be established the mechanism by which TCS reduces thyroid tissue 
activity in adult zebra fish. 
Key works: Triclosan, Propylthiouracil, thyroid disruptor, follicle inactivation, qPCR, 
and relative expression. 
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II. Resumo 
 
O número de químicos aos quais os organismos estão expostos diariamente por 
contaminação ambiental causada pela indústria e/ou agricultura tem vindo a aumentar. 
Há, no entanto, uma grande falha na informação sobre os efeitos biológicos destes 
contaminantes. 
Esta tese foca-se nos efeitos do agente antimicrobiano Triclosan (TCS), no 
tecido da tiróide de peixe zebra adulto. Após 21 dias de exposição dos animais, ao TCS 
(100 mg/Kg/dia) e ao agente Propiltiouracil (PTU, controlo positivo) (5 mg/Kg/dia) 
foram efectuadas observações histológicas em secções da faringe. Estas observações 
indicaram um aumento significativo (p<0.05) no tamanho dos folículos assim como 
inactivação dos tirócitos no grupo exposto ao TCS e redução da actividade dos tirócitos 
nos peixes tratados com PTU. 
Para compreender o modo de acção dos compostos, a expressão dos genes 
Tiroglobulina (Tg), Tiróide Peroxidase (TPO), Transportador Sódio-Iodo (NIS) e 
Catepsina B (CtsB), assim como Hormona Estimuladora da Tiróide (TSH), em toda a 
cabeça de peixe zebra foi estudada recorrendo à técnica de PCR quantitativo em tempo 
real (qRT-PCR). Após a normalização da amostra contra o gene gliceraldeido-3-fosfato 
dehidrogenase espermatogénico (GADPH-2), validado como gene referência neste 
estudo, detectou-se um aumento significativo (p<0.05) na expressão dos genes TSH e 
NIS. A expressão relativa da TSH aumentou nos grupos TCS e PTU, enquanto que a 
expressão do NIS mostrou aumento significativo apenas no grupo tratado com TCS. 
Nas restantes proteínas não foram detectadas alterações significativas das expressões 
possivelmente pela variação biológica entre os indivíduos. 
Os resultados obtidos indicam que o composto TCS, com uma concentração de 
100 mg/kg/dia por 21 dias, parece influenciar a síntese das hormonas da tiróide. O 
aumento da transcrição de TSH e NIS assim como a indução de inactividade do tecido 
da tiróide, observados neste trabalho, são efeitos indicativos da redução das hormonas 
da tiróide em circulação. É ainda necessário estudar qual o mecanismo através do qual o 
TCS reduz a actividade da tiróide nos peixes zebra adultos. 
 
Palavras-chave: Triclosan, Propiltiouracil, hipotiroidismo, inactivação folicular, qPCR, 
expressão relativa. 
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18 S 18 S ribosomal subunit 
ANOVA Analysis of variance 
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bp Base pair 
cDNA Complementary DNA 
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CtsB Cathepsin B 
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TPO Thyroid peroxidase 
TRH Thyroptropin releasing hormone 
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TSH Thyroid stimulating hormone 
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1. Introduction 
 
 
 
1.1  The Endocrine System 
 
The tissues and organs of the vertebrate body cooperate to maintain homeostasis 
of the body’s internal environment, through the actions of multiple regulatory 
mechanisms that involve many organs of the body [1]. The endocrine system regulates 
many of these mechanisms.  
The endocrine system sends information to the tissues using chemical substances 
released by the endocrine glands. These substances – hormones – are released into the 
circulatory system and transported to all parts of the body [2] thus establishing a 
complex interaction between organs, as represented in figure 1.1. 
 
 
Fig 1.1: Schematic representation of the relationship of endocrine organs with the body tissues. As seen in this 
scheme of the endocrine system, the organs share a rather complex relationship. Taken from [3]. 
 
 
A hormone is traditionally defined as a substance that 1) is produced in small 
amounts by a set of cells in endocrine glands, 2) is secreted into the interstitial spaces, 
3) enters into the circulatory system that carries it to other parts of the body, and 4) 
affects a limited number of cells, which are called target cells [2, 4]. However, it is now 
known that they may move by circulation in blood, other body fluids or diffuse between 
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cells, and may act in distant organs in the body (endocrine action) or the chemical 
regulatory molecules may be released and act within an organ regulating the same cell 
type which produced it (autocrine) or act in different tissues of the same organ 
(paracrine) [1]. 
The response of target cells to the hormone to which they are sensitive is due to 
the presence of hormone-specific receptors on the cells. These receptors might be found 
on the surface, extracellular receptors, or in the cytoplasm or nucleus of the cell, 
intracellular receptors. The type of hormone and the kind of receptors to which the 
hormone is associated, depends of the chemical nature of the hormone molecule. 
 
 
 1.2 Hormones  
  
Nature uses a diverse spectrum of molecules as hormones, and, like all 
molecules, hormones are synthesized, exist in a biologically active state for a time, and 
then degrade or are destroyed [4]. 
  
  Hormones belong to four different chemical categories: 
1. Polypeptides. These hormones are composed of chains of amino acids (aa) that 
are shorter than about 100 aa. 
2. Proteins. These are composed of a polypeptide significantly longer than 100 aa, 
that might be glycosylated. 
3. Amines. These are derived from the aa tyrosine and tryptophan. 
4. Steroids. These are lipidic hormones derived from cholesterol [1]. 
 
In a more general approach, hormones can be divided into those that are 
lipophilic (lipid soluble) and those that are polar (water-soluble). The lipophilic 
hormones – all of the steroid hormones and thyroid hormones – as well as other 
lipophilic regulatory molecules can easily enter cells through the lipid portion of the cell 
membrane. Water-soluble hormones, in contrast, cannot pass through cell membranes, 
and must regulate their target cells through different mechanisms at the cell surface [1]. 
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1.2.1 Hormones with intracellular receptors 
 
Hormones are found dissolved in plasma and are transported either in a free 
form or bound to plasma proteins [2] – carrier proteins, some being specific for a 
certain hormone. Lipophilic hormones are mainly transported bound to carrier proteins, 
as they do not dissolve in the plasma. When the hormones arrive at their target cells, 
they dissociate from carriers and diffuse through the plasma membrane. The hormone 
binds to specific intracellular receptors (the nuclear receptors) in the cytoplasm or the 
nucleus, and hormone-receptor complexes then act as ligand-dependent transcription 
factors in the nucleus, by binding to promoter regions of responsive genes and 
stimulating/repressing their transcription [1, 4]. The production of these 
responsive-genes and their protein products will then lead to the final effect of the 
hormone. 
 
 
1.2.2 Hormones with extracellular receptors 
 
Hormones that are too polar to cross the plasma membranes of their target cells 
include all of the peptide, amino acid derivatives and glycoprotein hormones. These 
hormones bind to receptor proteins located on the outer surface of the plasma 
membrane [1], initiating a series of events that are mediated by second messenger 
molecules [1, 4]. Second messengers include organic molecules and Ca2+, and changes 
in their concentrations in response to hormone-receptor binding trigger a cascade of 
intracellular signalling responses, generally involving the activation of multiple effector 
enzymes such as protein kinases, which lead to the hormone’s physiological effect.  
The binding of a water-soluble hormone to its receptor is reversible and usually 
very brief. After the hormone binds to its receptor and activates a second-messenger 
system, it dissociates from the receptor and may travel in the blood to another target cell 
somewhere else in the body. Eventually enzymes (primarily in the liver) degrade the 
hormone by converting it into inactive derivates [1]. 
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1.2.3 Control of Endocrine Activity 
 
The physiologic effects of hormones depend largely on their concentration in 
blood and extracellular fluid. Thus, precise control over circulating concentration of 
hormones is therefore crucial [4]. 
The concentration of hormone that reaches target cells is determined by: 
- Rate of production: the synthesis and secretion of hormones is the most highly 
regulated aspect of endocrine control. Such control is mediated by positive and 
negative feedback circuits. 
- Rate of delivery: an example of this effect is blood flow to the target organ or 
to a group of target cells – high blood flow delivers more hormone than low blood flow. 
- Rate of degradation and elimination [4]. 
 
Feedback circuits are at the root of most control mechanisms in physiology, and 
are particularly prominent in the endocrine system. Instances of positive feedback 
certainly occur, but negative feedback is much more common [4]. Negative feedback 
ensures that the cellular concentrations of products determine the rates of their 
formation, thus ensuring that the cell synthesizes only as much as it needs [5].  
 
1.3 Thyroid hormones 
 
Thyroid hormones (TH) are small liposoluble molecules with two bioactive 
forms, tetraiodo-L-thyronine (thyroxine, T4) and triiodo-L-thyronine (T3), which 
contain four or three iodine atoms respectively [6], as showed in figure 1.2. 
Thyroxine
(T4)                   
Triiodo-L-thyronine
(T3)
Iodine Oxigen
HidrogenCarbon
Nitrogen
 
Fig 1.2: Molecular structure of the two thyroid hormone bioactive forms, thyroxine and triiodo-L-thyronine. Taken 
from [7]. 
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THs stand out from all others present in vertebrates since they are the only 
iodine-containing compounds of physiologic significance [8]. 
THs are produced by all vertebrates, primarily as T4 in the thyroid gland and 
are subsequently converted to the more bioactive T3 form in peripheral tissues through 
the action of a family of enzymes the deiodinases [9].  
These hormones are known to play a crucial role in maintenance of normal 
physiological functions [10] as they stimulate oxidative respiration in most cells in the 
body and, in doing so, help to set the body’s basal metabolic rate [1].  
THs are present in all vertebrates. For instance in children, they promote growth 
and stimulate maturation of the central nervous system, while in amphibians THs are 
needed for the metamorphosis of the larvae into adults [1]. In avian species, THs are 
required for nervous system and skeleton development [8].  
In fish, TH action has also been demonstrated to regulate both larval and 
metamorphic development. It has also been showed that at later life stages in fish, THs 
assist in the control of various physiological functions including osmoregulation, 
metabolism, somatic growth, development, metamorphosis, etc. [11].  
Although THs regulate many biological functions, their levels are also 
influenced by nutritional status in both endothermic (birds, mammals) and ectothermic 
(fish) vertebrates and poor nutrition is linked with a decreased T3 and T4 [8]. 
 
For the correct concentrations of THs to be maintained there are mechanisms 
which regulate THs synthesis. These mechanisms are found in the Hypothalamic-
Pituitary-Thyroid (HPT) Axis, which, as the name indicates, consists of the 
hypothalamus, pituitary and the thyroid gland. 
 
 
1.3.1 TH regulation 
 
The activity of the thyroid gland, and all structures associated in the HPT axis, is 
predominantly regulated by the concentration of the pituitary glycoprotein hormone, 
thyroid stimulation hormone (TSH). Thus, regulation of thyroid function in normal 
individuals is to a large extent determined by the factors which regulate the synthesis 
and secretion of TSH. Those factors are mainly thyrotropin releasing hormone 
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(TRH), produced in the hypothalamus, and the feedback effects of circulating THs at 
the hypothalamic and pituitary levels of TRH and TSH (“thyrotropin”) [8].  
TRH is delivered to the pituitary gland and selectively stimulates the synthesis 
of the TSH beta subunit. Pituitary TSH is composed of two sub-units, alfa and beta [10]. 
The beta subunit confers specificity to the molecule, since it interacts with the thyroid 
cell TSH receptor leading, through enzymatic activity, to the increase in TH synthesis 
and liberation [8]. However, the TSH beta sub-unit in its free form is inactive, and 
requires non-covalent combination with the alfa subunit to express hormonal bioactivity 
[8].   
TRH synthesis and release are regulated by the THs, an integral part of the 
negative feedback loop regulating thyroid status [8]. On the other hand, the major 
regulators of TSH production are represented by the inhibitory effects of thyroid 
hormones (negative feedback loop) and by the stimulatory action of TRH (figure 1.3) 
[8]. 
 
 
Fig 1.3: Fig.  Schematic representation of the basic elements of the Hypothalamic-Pituitary-Thyroid (HPT) Axis: 
main glands and respective hormones. TRH is secreted by the hypothalamus and stimulates the pituitary to secret 
TSH, which then stimulates the thyroid to release T3 and T4. These hormones in turn will stimulate the target cells 
and regulate by negative feedback TRH and TSH synthesis. 
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1.3.2 Thyroid tissue 
 
 The thyroid tissue is composed of functional units called the thyroid follicles. 
The follicles are lined by a simple epithelium and their central cavity contains a 
gelatinous substance called colloid [12] (figure 1.4).  
 
 
Fig 1.4: Representation of thyroid tissue showing the thyroid follicles containing colloid which is enclosed by a 
monolayer of epithelial cells. Taken from [13]. 
 
 The specialized epithelial cells found in the thyroid follicles concentrate iodide 
and incorporate it into thyroglobulin (Tg), which is subsequently hydrolysed to release 
THs. These processes require cell-type specific gene-products, which include Tg, 
thyroid peroxidase (TPO), the receptor for the thyroid stimulating hormone 
(RTSH) and sodium-iodide symporter [14], as explained below.  
 As mentioned in section 1.2.1, TSH has an important role in TH regulation. This 
hormone interacts with its receptor found in the thyroid cells which leads to 
transcription of the Tg, TPO, RTSH and NIS genes [10].  
   
Although THs and thyroid tissue are present in all vertebrates there exist 
significant differences among species. In general, the gland is often a collection of 
aggregated follicles as described for mammals, highly vascularised and encapsulated by 
connective tissue [10]. However, the thyroid of many teleosts is not a compact single 
organ. They have the thyroid follicles loosely distributed within the mesenchyme of the 
ventral head area [11], although it maintains the tissue organization as thyroid follicles. 
Despite these structural differences, the biochemistry and regulation of thyroid 
hormone synthesis are identical [10]. 
 
 
 8 
 1.3.3 Hormone Synthesis 
 
 Synthesis and accumulation of THs takes place in four stages: synthesis of 
thyroglobulin, uptake of iodide from the blood, activation of iodide, and iodination of 
the tyrosine residues of thyroglobulin [12] (figure 1.5). 
 
Fig 1.5: The thyroid follicular cell and the process of synthesis and secretion of THs. These events may occur 
simultaneously in the same cell. Taken from [12]. 
  
 Synthesis of thyroglobulin – Tg is the substrate from which THs are 
synthesised [10]. Tg is secreted from the thyrocytes into the follicular lumen to form the 
colloid [15]. Tg is synthesised by ribosomes bound to the rough endoplasmatic 
reticulum and then transported to the Golgi apparatus, where carbohydrate moieties are 
added [10, 16]. Then Tg is released from vesicles which form at the apical surface of the 
cell into the lumen of the follicle where tyrosine residues are iodinated and where it is 
condensed to produce the thyroid hormones, T3 and T4. T3 and T4 remain covalently 
bound to Tg as long as they are stored in the lumen [12, 17]. 
  
 Uptake of circulating iodide – is accomplished in the thyroid follicular cells 
[12]. The iodide uptake across the basolateral membrane of polarized cells is dependent 
of a specific transporter, the Na+/I- symporter or NIS. This is an intrinsic plasma 
membrane protein on the thyroid epithelial cells, structurally and functionally conserved 
among vertebrates [10, 18, 19], that passively transports two Na+ and one I- down the 
Na+ ion gradient, resulting in an iodine concentration gradient from the thyroid cell to 
the extracellular fluid. The iodide gradient can be increased to as high as 1:400 in 
conditions of iodine deficiency [16]. Serum iodine plays an important role in regulating 
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thyroid function because low iodine levels increase the amount of NIS, and thus 
increase iodide uptake, compensating for the lower serum concentration [12]. 
  
 Iodide oxidation – Iodide, the form of iodine that enters the cell, must be 
oxidized to a higher oxidation state before it is transferred to Tg. Oxidation of iodine is 
controlled by the enzyme thyroid peroxidise (TPO) [10], a membrane-bound 
glycoprotein with a central role in thyroid hormone synthesis catalysing iodide 
oxidation, iodination of tyrosine residues in Tg, and iodothyronine coupling [16]. Like 
Tg and NIS, the TPO enzyme is also highly conserved among vertebrates [10]. After the 
iodide is oxidised, another transport protein of the cell is involved, pendrin, that 
functions as an apical porter of iodide in the thyrocyte, transporting iodide into the 
follicle lumen [20]. 
  
 Iodination of tyrosine residues – There are four major sites on the Tg protein 
where iodine becomes covalently attached. These “sites” are tyrosyl residues that accept 
an iodine atom as the consequence of TPO activity. Tg  appears to be iodinated at the 
interface colloid-thyroid follicle cell [10], to produce MIT (monoiodotyrosine) and DIT 
(diiodotyrosine) [8]. Specific tyrosyl residues are coupled within the backbone structure 
of Tg, and this is the material stored in the colloid of the thyroid follicle [10], in the 
form of a matrix of covalently cross-linked material. 
 
THs are stored in the colloid as part of the iodinated Tg molecule. Therefore, 
prior to their secretion from the thyroid gland, T4 and T3 must be released from the 
peptide linkage within Tg [10]. 
 
 
1.3.4 Thyroxine production and release 
 
Thyroid hormone liberation begins with the solubilisation of Tg from its matrix 
of covalently cross-linked material. Proteolysis is a necessary prerequisite for 
solubilisation of Tg from the globules and must precede its endocytosis by thyroid 
epithelial cells, leading to the rapid liberation of T4 [10]. 
Mature and proteolytically active cathepsins belonging to the papain family have 
been shown to provide thyroid epithelial cells with a mechanism of extracellular 
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degradation of Tg at the apical plasma membrane [21]. The proteolytic enzymes 
described as being involved in solubilisation of Tg and its posterior degradation are 
cathepsin B, L and K. 
Friedrichs et al. [22] have shown that the lack of expression of single or multiple 
cathepsins caused a reduction in circulating levels of T4 and altered the histological 
appearance of the colloid itself. Specifically, in the absence of enzymes (cathepsins B 
and L) that solubilise the cross linked Tg in the colloid, the material cannot be removed 
from the colloid and the follicle continues to expand as the result of continued synthesis 
of Tg [10]. 
The secretion of lysosomal enzymes from thyroid epithelial cells is a regulated 
process. Secretion of mature cathepsin B is triggered by TSH [21] and it is transported 
to endososmes/lysosomes in which it matures to become an active peptidase. After 
endocytosis, the Tg backbone is broken down by the action of lysosomal enzymes after 
fusion of the endosome with a secondary lysosome [10], as schematically presented in 
figure 1.6. The enzymes responsible for Tg degradation are not unique to the thyroid 
gland but are common lysosomal enzymes [10]. 
 
 
Fig 1. 6: Schematic representation of T3 and T4 production and liberation through Tg solubilisation and degradation 
by the activity of proteolytic enzymes such as Cathepsins B, L and K, in the thyroid follicular cells. Taken from [22]. 
 
The metabolic pathway required to liberate T4 and T3 from the Tg molecule is an 
important physiological event and its potential disruption by environmental chemicals 
may be an important mechanism by which adverse effects of specific toxicants can 
occur [10]. 
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1.4 Endocrine disruptors 
 
Endocrine disruptors (EDs) are exogenous substances that act like hormones in 
the endocrine system and disrupt the physiologic function of endogenous hormones [7].  
Endocrine-active compounds can be natural and synthetic hormones or industrial 
chemicals which interfere by stimulating or inhibiting the binding or synthesis of 
hormones or their receptors and binding proteins [23]. 
EDs act in very small doses but generally over a long period of time. So, the 
relevant doses of EDs in the environment are minute, but with the capacity of affecting 
the organisms. Since the majority of chemicals with ED ability are also persistent in the 
environment and bioaccumulative, it’s difficult to establish a direct relation to the 
effects of one single substance [24].  
 
Fig 1.7: Schematic representation of the normal response of a cell to a hormone (left) and for the some of the 
endocrine disruption mechanisms – hormone mimic (middle) and hormone blockage (right). Image taken from [25]. 
 
Some chemicals mimic a natural hormone, leading the body to respond to the 
stimulus (as in figure 1.7, middle), or respond at inappropriate times. Other EDs block 
the effects of a hormone by binding to certain receptors (figure 1.7, bottom). In 
addition, others directly stimulate or inhibit the endocrine system and cause over or 
underproduction of hormones [26].  
 
 
1.4.1 Thyroid disruptors – Goitrogens 
 
The sensitive and tightly regulated feedback control system (thyroid gland 
autoregulation) and the large intrathyroidal storage pool of THs serve to provide a 
constant supply of thyroid hormone to peripheral tissues, even if perturbations are 
imposed by external environment, chemicals and drugs [8]. This work focused on 
perturbations of the HPT axis by chemicals and drugs. Many drugs affect the transport, 
metabolism, action and excretion of T4 and its derivatives as well as regulation at all 
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levels of the HPT axis [8]. 
Irrespective of their mechanism of action, they are collectively called 
goitrogens, because as a result of a decrease in serum TH level, TSH secretion is 
enhanced, causing goiter formation. Among the goitrogens, the least toxic and those 
possessing the highest thyroid-inhibiting activity are clinically used in the treatment of 
hyperthyroidism [8]. 
 
 
1.4.1.1 Anti-thyroid drugs 
 
An anti-thyroid drug is any agent or substance which suppresses, prevents or 
opposes the biosynthesis of thyroid hormones [27]. According to their principal mode of 
action on thyroidal iodine metabolism, antithyroid drugs are divided into two 
categories: 1) the monovalent anions which inhibit iodide transport into the thyroid 
gland, and 2) a large number of compounds that act through inhibition of thyroidal 
iodide binding and iodotyrosine coupling. The most important representatives of this 
latter category of compounds are the group of thionamides.  Certain monovalent anions 
inhibit the transport of iodide into the thyroid gland and thereby depress iodide uptake 
and hormone formation [8]. 
On the other hand, the thionamide group of goitrogens does not prevent transport 
of iodide into the thyroid gland, but rather impairs covalent binding of iodide into Tg. 
They may be competitive substrates for TPO, preventing the peroxidation of iodide by 
this enzyme [8]. 
From a medical point of view, anti-thyroid agents can be defined as agents that 
are used to treat hyperthyroidism by reducing the excessive production of thyroid 
hormones [27] the most commonly used drug is Propylthiouracil (PTU). 
 
 
1.4.1.1.1 Propylthiouracil (PTU) 
 
PTU is a derivative of thiocarbamide. It is an anti-thyroid, reversible goitrogen 
drug, effective and safe in the treatment of hyperthyroidism [28] with a well-known 
mechanism of action: it inhibits intrathyroidal synthesis of thyroid hormones by 
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interfering with the iodine utilization by TPO and with the coupling of MIT and DIT 
required for the formation of T3 and T4. Furthermore, it blocks the peripheral conversion 
of T4 to T3 [29], thus maintaining the T4 concentration in blood at a higher level that is 
normal. 
 
 
 
Fig 1.8: 3D Molecular structure of the thyroid disruptor PTU. Taken from [7]. 
 
 
 According to INFARMED, Autoridade Nacional do Medicamento e Produtos 
de Saúde, I. P., (the Portuguese entity for medical drugs regulation) the doses for PTU 
for clinical application are 300 to 600 mg/day for adults until clinical control, following 
a gradual reduction to maintenance doses  of 50 to 100 mg/day [30]. 
 
 
1.4.1.2 Environmental thyroid disruptors 
 
A large number of substances may affect thyroid gland function and thyroid 
hormone metabolism and action. The list continues to grow with the introduction of 
new diagnostic agents, drugs and food additives [8]. 
A number of chemical contaminants are suspected to display endocrine 
disrupting activity at environmentally relevant concentrations and may interfere with 
normal growth and developmental processes that involve THs [31-33]. 
Environmental chemicals may interfere with thyroid homeostasis through many 
mechanisms of action, such as binding to transport proteins, in cellular uptake 
mechanisms or by modifying the metabolism of THs. Several environmental chemicals 
have a high degree of structural resemblance to T4 and T3, and therefore interfere with 
binding of THs to receptors or transport proteins. 
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There is substantial evidence that polychlorinated biphenyls (PCBs), dioxins and 
furans cause hypothyroidism in exposed animals and that environmentally occurring 
doses affect human thyroid homeostasis. Similarly, flame retardants reduce peripheral 
TH levels in rodents, but human studies are scarce. Studies also indicate thyroid 
disruptive properties of phthalates, some stimulate TH production, contrary to most 
other groups of chemicals [34]. 
The aquatic environment and organisms such as fish are constantly threatened by 
pollution resulting from human activity [35]. Pharmaceutics and personal care products 
(PCPs) represent a source of prevalent contaminants in the aquatic environment, and 
many can be present as complex mixtures within municipal waste effluents. One such 
contaminant is the bactericidal agent triclosan (TCS) [36]. 
 
 
1.4.1.2.1 Triclosan 
 
TCS (2,4,4’ – trichloro  -2’ - hydroxydiphenyl ether; synonym: Irgasan DP 300) 
is a synthetic, broad-spectrum antimicrobial agent that in recent years has exploded onto 
the consumer market [37]. It is used in the manufacture of a variety of commercial 
products including clothing, materials for food processing, PCPs (e.g. soaps and 
toothpaste) and surgical items (e.g. sutures) [38-44].  
Carbon
Oxigen Cloride
Hidrogen
 
Fig 1.9: 3-D molecular structure of the thyroid disruptor Triclosan. Taken from [7]. 
 
  
Rather than being a general biocide (a chemical substance that disrupts so many 
cellular functions at once that bacteria encountering it simply cannot survive), TCS may 
instead be a specific biocide, killing bacteria by targeting specific cellular functions by 
blocking essential enzymes for fatty acid synthesis. However, this allows the bacteria to 
mutate, thus building up resistance and developing into “superbugs” [45]. 
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Its ubiquitous usage in consumer products has led to widespread environmental 
contamination evidenced by detection of TCS in wastewater effluent in the US, UK, 
Japan and other countries [38-44]. Concentrations in the range of 0.01 – 0.65 µg/L in 
sewage effluent and 0.4 – 12 µg/L in sludge have recently been recorded from sewage 
treatment plant sites in North America and Europe [38-44].  
During wastewater treatment, many of the chemicals, including biocides, are 
removed, but some chemicals still reach surface water [46]. It’s the case of TCS, 
making this an important aquatic environmental contaminant. 
The release of TCS into the environment is of particular concern as it is 
structurally similar to THs (fig 1.10) and may, therefore, represent a potential disruptor 
of TH action particularly as TCS or its derivatives bioaccumulate in the tissues of 
wildlife species [35].  
 
 
Fig 1. 10: Chemical structures of the THs (T3 and T4) and of the goitrogen TCS. Taken from [7]. 
 
 
 
1.5 Objective 
 
The number of chemicals to which humans are exposed increases as do the 
quantities which accumulate in the environment, the real effects of these chemicals 
remain unknown but they may alter whole body homeostasis by affecting the endocrine 
system. Among all the glands that belong to the endocrine system, this work focuses on 
the HPT axis, especially the thyroid gland. There are studies which show that the HTP 
axis is very susceptible to some classes of man-made chemicals, especially as some of 
those chemicals show high structural resemblance to TH hormones, thus changing the 
equilibrium needed for optimal functioning of the thyroid gland. In some cases of TH 
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alterations, the changes may be detected as goitrogen, i.e. the enlargement of the thyroid 
gland. To evaluate the presence of such abnormalities in the thyroid gland, histological 
techniques were applied. 
The thyroid gland enlargement occurs at a molecular level by alterations to TH 
synthesis. Among the proteins involved in TH synthesis, Tg, CtsB, TSH, NIS and TPO 
are among some of the most important, and are susceptible to the presence of some 
chemical. Using molecular tools, such as qRT-PCR, the level of expression of the 
mRNA for these proteins was evaluated in this study.  
The goal of this work was to study the effects of TCS on the disruption of the 
thyroid axis by evaluating its effects through a molecular and functional analysis in an 
in vivo assay. 
 
 
1.5.1 Goitrogen choice 
 
The potential endocrine disrupting behaviour of TCS was studied in rats as it has 
previously been reported to alter the level of thyroid hormones in animals [47]. 
Moreover, the daily exposure to this agent is not insignificant as it has widespread 
applications in everyday products such as detergents, kitchen sponges, soaps, 
deodorants, cosmetics, lotion, antimicrobial creams, (…), various plastics including 
children’s toys, paint, wallpaper, flooring, textiles, curtains, keyboards, countertops 
[48].  
 
 
1.5.2 Experimental Model 
 
Since the present study consisted of an in vivo study of TCS, it was necessary to 
choose a suitable animal model. Having in mind that the objective of the work included 
the functional analysis of the goitrogenic action of TCS, the zebrafish was chosen. 
Zebrafish (Danio rerio a small tropical freshwater fish) from the family 
Cyprinidae that rarely grows beyond 50–60 mm in length and was first used as a genetic 
model system is the early 1980s. The zebrafish shares numerous anatomical similarities 
with higher vertebrates, including humans, both in the general body plan and in specific 
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organs. Close parallels exist in many aspects of early embryogenesis and in the 
anatomical and histological features of the brain, spinal cord, sensory systems, 
cardiovascular system, and other organs. Not infrequently, genetic defects in zebrafish 
resemble human disorders [49].  
Also the large base of established knowledge on the developmental biology and 
genetics of the zebrafish and the detailed genetic map of this species genome facilitates 
the identification of modifications in gene expression during endocrine disruption [50]. 
 
 
Fig 1.11: Danio rerio (zebrafish). 
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2. Methodology 
 
 
The experimental work consisted of in vivo exposure of zebrafish to a goitrogen 
(TCS) in order to evaluate its effects on thyroid gland morphology and mRNA 
(messenger ribonucleic acid) expression of key genes encoding proteins involved in the 
synthesis of the THs namely, TSH in the pituitary gland and Tg, TPO, NIS and isoform 
a of CtsB in the thyroid. 
The fish were exposed orally to PTU a goitrogen commonly used in 
hyperthyroidism treatment and whose effects on thyroid hormone levels are well studied 
for different classes of organisms, including fish [23, 51] and the bactericide TCS. The 
results of administering PTU served as a reference to which the effects of TCS could be 
compared. 
For morphological evaluation of the thyroid, the whole head was processed for 
histological analysis and several parameters were measured in thyroid follicles, such as 
internal and external areas, vacuolation and height of the epithelium. 
The evaluation of whole head mRNA expression was achieved through the 
application of a number of molecular tools, such as Polymerase Chain Reaction (PCR), 
for amplification and cloning of templates and qualitative analysis of tissue expression 
for key genes, and real-time quantitative PCR (qPCR) to analyse modifications in gene 
expression. For the successful application of the previous tools, in silico identification 
of the target gene was needed, to obtain the predicted cDNA sequences of the proteins 
of interest. 
 
 
2.1 Experimental conditions 
 
For the duration of the treatment, 21 days, a total of 48 zebrafish imported from 
Thailand, were weighted and randomly distributed into 6 tanks (8 individuals per tank), 
containing 5,5 L of freshwater at room temperature (26ºC) and under 12h light:12h dark 
photoperiod. Water aeration and circulation were achieved using a pump, and water was 
renewed once a week by replacing approximately 2/3 of the total volume of the tank 
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with dechlorinated fresh water. The fish were fed once a day with dry food pellets at 3% 
per kg of fish.  
 
2.1.1 Goitrogen dose 
 
The treatment with TCS (or Irgasan, Fluka, Sigma-Aldrich, Madrid, Spain) was 
carried out at a daily dose of 100 mg/kg. This dose was defined based on a study by 
Crofton et al. 2008 [47] in mice, which show that serum T4 decreased in a dose 
dependent manner, as the dose of TCS increases. According to the results of the study, 
the lowest TCS concentration tested which caused a significant decrease in the T4 levels 
was 100 mg/Kg/day. 
 
Treatment with PTU (Sigma-Aldrich), the positive control treatment, was carried 
out at a daily exposure rate of 5 mg/kg. This dose was selected based upon the 
information available from INFARMED [30], in which the recommended exposure, for 
adults was of 300-600 mg/day (assuming that a human adult weighs approximately 
60 kg, the daily exposure dose consisted of 5 to 10 mg/kg/day). The dose of PTU 
chosen was further supported by the study by Villar et al, in which a PTU dose of 4.4 
mg/kg/day up to 35 mg/kg/day resulted in lower concentrations of circulating T4 [52]. 
Also in previous works from the Molecular and Comparative Endocrinology (MCE) 
group in fish, concentration of 1mg/kg/day PTU was tested. This concentration did not 
induced hypothyroidism [53].  
  
2.1.2 Drug administration 
 
The fish exposure to the goitrogens TCS and PTU was achieved orally by 
applying the drugs in the food. The daily dose of food administered to the animals in 
each tank was determined assuming that each fish ate approximately 3% of its total 
body weight. The total mass of goitrogen administered was determined taking into 
account the sum of the body weight of all the fish per treatment group, prior to 
acclimatization (table 2.1), and the previous established doses (100 mg/kg/day for TCS 
and 5 mg/kg/day for PTU). 
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Table 2.1: Total body weight (g) for the different groups (n=10) acquired prior to acclimatization. 
Tank Total body weight (g) 
Control 1 3.27 
Control 2 3.14 
PTU 1 2.69 
PTU 2 3.37 
TCS 1 2.67 
TCS 2 3.25 
 
 Stock solutions of TCS (1 mg/mL) and PTU (10 mg/mL) were prepared by 
dissolving the drugs, weighted using a precision balance, in 95% ethanol in glass tubes. 
The appropriate volume of stock solution required to attain the desired concentration 
was diluted to reach a final volume of 100 µL. The food pellets were then immersed in 
each drug solution (TCS and PTU) or in ethanol only (control group) and then allowed 
to dry in a fume cupboard. 
The dried food pellets were administrated to replicate tanks (n=2) for each 
treatment. 
 
 
2.2 Sampling 
 
After 21 days treatment, all the animals were collected (n = 8 per tank) and 
placed in a vessel containing anaesthetic (2-phenoxyethanol, Sigma, diluted at 1:2,000 
in fresh water) in order to euthanize the animals. Once euthanized, the animals were 
weighted and their standard length [54] measured. Half of the individuals from each 
tank were immersed in liquid N2 and stored at -80ºC until RNA extraction, while the 
other half were immersed in fresh 4% paraformaldehyde (PFA1) after nicking the 
abdomen to ensure good penetration of the fixative and stored at 4ºC. 
 
 
2.3 Histological Analysis 
 
The histological analysis was carried out on the tissues of the whole head, where 
the thyroid gland is located, due to the small size of the animals and the dispersed nature 
                                                 
1
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of the thyroid tissue in fish. The animals (8 fish per group) immersed in the 4% PFA 
fixative were washed twice in PBS 1X, 30 minutes each, and a final wash with 
diethylpyrocarbonate (DEPC)-treated water2 carried out for 30 minutes. The samples 
were then immersed in ethanol 70% in DEPC-treated water and stored at 4ºC.  
 
 
2.3.1 Tissue processing 
 
The head was isolated from the rest of the animal by cutting off the operculum 
(gill cover) followed by severing of the head. All tissues were decalcified (removal of 
calcium ions to soften tissue) [7] in EDTA 0,5M, pH 8,0 for 6 days with agitation and 
kept away from light. 
Decalcification of the head tissues was followed by paraffin embedding using a 
Leica TP1020 tissue processor, where the tissues were dehydrated through immersion in 
a gradient of ethanol, 70% (10 min), 95% (30 min x2)  and 100% (1 hour x2) followed 
by a mixture of ethanol:xylene (1:1) (1 hour), saturated xylene (100%) (1 and 1.5 
hours), a mixture of xylene:paraffin (1:1) (2 hours) and paraffin (100%) (2 hours). Once 
the paraffin embedding ended, the tissues were used to prepare the paraffin blocks in 3 
consoles: thermal, dispensing and cryo (Miles Scientific), obtaining a total of 6 blocks, 
4 heads per block. Serial sections of 5µm were obtained from each block using a 
Leica RM 2135 microtome and were mounted on glass slides coated with 
Aminopropyltriethoxysilane (APES)3 (Sigma-Aldrich) and dried overnight (ON) at 
37 ºC.  
 
 
2.3.2 Staining 
 
In order to identify the thyroid structures, the tissues were stained using the 
Cleveland-Wolfe trichrome method. This method stains the colloid in thyroid follicles 
bright red while the epithelium stains blue or purple. 
                                                 
2
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The first steps of this staining consist of removal of paraffin wax and rehydration 
of the tissues. The tissues were immersed for 15 min in K-Clear (Kaltec, Padova, Italy), 
twice, followed by the immersion in a descending series of ethanol dilutions (100% for 
10 min, 95% and 70% for 5 min each). The rehydration ended with a 5 min immersion 
in distilled water. Rehydrated tissues were immersed for 5 min in Erlich’s haematoxylin 
followed by a wash in tap and distilled waters. The tissues were dipped for 5 min in 1% 
aqueous Erythrosine and washed with tap and distilled waters. The tissues were stained 
for 8-10 sec with Orange G (2% in 1% phosphotungstic acid) followed by a fast wash in 
distilled water before staining with Aniline Blue (0,25% aqueous solution acidified to 
pH 3-4) for 90 sec. The tissues were then quickly washed in 100% ethanol, incubated 2 
x 5 min in K-Clear and mounted for definitive preparation in DPX (Fluka, Sigma). 
 
The tissues were examined in an Olympus BH2 microscope for the presence or 
absence of colloid and vacuolation in thyroid follicles, follicular epithelial folding and 
evaluation of follicular size. The internal/external areas and the cell height were 
measured for sections from control (n = 4), TCS (n = 6) and PTU (n = 4) treated 
zebrafish using the software ImageJ (freeware-NIH) [55] for digital analysis from the 
photographs taken from an Olympus DP11 digital camera. The cell height of 2 different 
thyrocytes per follicle, lying 90º from one another, was also measured for 4 individuals 
in each of the experimental groups.  
  
 
2.4 Molecular Analyses  
 
To study if the goitrogens had an effect in the level of expression of the mRNAs 
for key proteins involved in TH synthesis (CtsBa, Tg, TPO, TSH and NIS), it was 
important first to isolate the genetic material – the RNA from whole head tissues (where 
the thyroid gland and pituitary gland are found). So, prior to RNA extraction, the head 
and body were separated. 
As the study was centred on specific gene products, it was also important to test 
their presence in the extracted RNA. This was achieved by complementary DNA 
(cDNA) synthesis from whole head RNA from control fish, and the use of specific 
primers for PCR. These PCR reactions also provided the specific cDNAs to clone each 
 23 
gene product into a vector, and each cDNA fragment + vector construct was introduced 
into host cells transforming them. After multiplication of the host cells, each construct 
was extracted, its identity was confirmed by digestion and sequencing, and it was also 
used as a standard in qPCR with specific primers, which allowed the quantification of 
gene expression in the different experimental groups. 
 
 
2.4.1 RNA extraction and Quantification 
 
For RNA isolation from the head, frozen animals (n=8 per group) were placed 
on a hard surface, and the heads were severed with a sharp blade. To avoid RNA 
degradation by the RNases present in the tissues, they were maintained in liquid N2 for 
part of the tissue isolation.   
The extraction was performed using TRI reagent (TRI, Sigma-Aldrich), 
following the protocol provided by the company and a manual glass homogenizer. The 
previously severed and crushed tissue was removed from liquid N2, immersed in 400 µl 
of TRI at room temperature and homogenized. The final mixture was transferred to a 
fresh tube and incubated at room temperature for 5 minutes. 0.2 mL of chloroform/ml 
TRI was added; the mixture was vigorously mixed and left to incubate at room 
temperature, and then centrifuged at 12000xg, 15 min, 4ºC. The (superior) aqueous 
phase was carefully removed to a fresh tube to which 0.5 ml isopropanol/ml TRI was 
added. The solution was incubated at room temperature followed by a centrifugation 
step at 12000xg, 15 min, 4ºC to pellet the RNA. The isopropanol was discarded and the 
pellet washed twice with 1 ml of cold ethanol 75% in DEPC-treated water/ml TRI used. 
The mix was centrifuged at 12000xg, 10 min, 4ºC and ethanol removed by inversion of 
the tube. The pellet of RNA was allowed to dry on ice and ressuspended in 200 µl 
DEPC-treated water (to avoid RNase contamination). 9 µl of ressuspended RNA 
(diluted 1:10) was applied on 1.5% electrophoresis to evaluate RNA integrity, another 
aliquot was stored directly at -80ºC (working aliquot), while 2.5 V (volumes) of 100% 
ethanol and 0.1 V of 3M potassium acetate (KAc)  were added to the remaining volume 
and stored at -80ºC (long-term storage aliquot).  
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The RNA in the samples was quantified using the Qubit™ fluorometer and the 
Quant-iT™ RNA Assay kit (Invitrogen, Carlsbad, CA, USA). Quant-iT™ Assay kits 
utilize advanced fluorophores that become fluorescent upon binding to DNA, RNA, or 
proteins; the fluorescence intensity of the resulting complex depends directly on the 
amount of the target molecule in the sample. The Quant-iT™ Reagents only report the 
molecule of interest – there’s no interference from free nucleotides or other 
contaminants (the assay Quant-iT RNA assay is highly selective for RNA over double-
stranded DNA)[56]. 
 As described in the protocol provided with the kit, the Quant-iT™ working 
solution was obtained by diluting of Quant-iT™ RNA reagent 1:200 in Quant-iT™ 
RNA buffer. 1 µl of the samples (each RNA diluted 1:10) and 10 µl of each standard 
(standard 1 and 2) were loaded in the assay tubes to which 199 µl and 190 µl of working 
solution were added to the tubes, respectively. The equipment was calibrated with the 
prepared standards followed by the reading of the samples concentrations. 
 
 
2.4.2. Removal of genomic DNA contamination 
 
During the RNA extraction, it is isolated from a mixture of DNA and other 
molecules such as proteins and lipids. Although a great part of the genomic DNA 
(gDNA) is removed during extraction with TRI reagent, it is necessary to assure that all 
the gDNA contamination is removed prior to qRT-PCR and for this reason samples 
were treated with DNase. This step was carried out using the DNA-free™ Kit 
(Ambion®, UK). 
DNase treatment was carried out on 4 µg of RNA which was transferred into a 
fresh tube to which 2 µl DNase buffer, 1 µl recombinant DNase I, and nuclease-free 
water, were added, to obtain 20 µl of reaction solution. The solution was mixed gently 
and incubated for 30 min at 37ºC. 2 µl of inactivation reagent were added and incubated 
at room temperature for 2 min with occasional vortexing. The mixture was centrifuge at 
10000xg, 1.5 min, 4ºC, placed on ice and the supernatant was carefully transferred to a 
fresh tube. 1 µl of a 1:5 dilution of the treated solution was quantified as described in 
section 2.4.2.1. 
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2.4.3 Complementary DNA (cDNA) synthesis 
 
cDNA is a single-stranded DNA molecule with a nucleotide sequence that is 
complementary to an RNA molecule, and it is synthesised by the enzyme reverse 
transcriptase (RT) from an RNA template [57]. It also differs from genomic DNA 
because, like mRNA, it does not contain non-coding sequences that are present in 
genes, the introns. 
 
The synthesis of cDNA (reverse transcription) was carried out in a Robot-Cycler 
thermocycler (Stratagene, La Jolla, USA) using 500 ng of DNAse-treated RNA, 200 ng 
of pd(N)6 random hexamers (GE Healthcare, UK), 1 µl of 
deoxynucleotide-triphosphates (dNTPs) (GE Heathcare, 10 mM each) and sterile water 
to a final volume of 13µl. The mix was heated to 65ºC for 5 min and incubated on ice 
for 5 min. 40U of MMLV reverse transcriptase (Promega, VWR, Portugal), 5U of 
RNAguard Rnase inhibitor (GE Healthcare) and 1x reverse transcriptase buffer 
(Promega) were then added, in a final volume of 20µl. The samples were run in a 
synthesis reaction for 10 min at 25ºC, 50 min at 42ºC synthesis was terminated by 
incubation for 5 min at 72ºC. A –RT control (cDNA synthesis in the absence of RT 
enzyme) for one of the samples was also performed, to control for genomic DNA 
contamination. 
 
2.4.4 In silico identification of predicted cDNA sequences  
 
The in silico studies allowed the identification of the gene sequences that 
correspond to the gene encoding the proteins to be studied as well as acquiring 
information about the cDNA sequences.    
Predicted cDNA nucleotide sequences for the genes of interest (CtsBa, Tg, TPO, 
TSH and NIS) were obtained by searching the zebra fish genome database of the 
National Centre for Biotechnology Information (NCBI, www.ncbi.nlm.nih.gov), using 
the query by gene name. The predicted cDNAs were retrieved from the database, and 
their identity was confirmed by comparison of their translated sequence with 
homologous proteins from other organisms, using BlastX against the non-redundant 
protein sequence database (nr) [58]. 
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For the target genes that were not found in the genome using the query by gene 
name, homologous cDNAs from other organisms were retrieved from NCBI and used to 
find the predicted protein in the zebra fish genome by BlastX at the NCBI site. The 
predicted zebra fish cDNA was retrieved and its identity confirmed by BlastX against 
the nr protein database.    
In order to find the cDNA/protein sequence for genes with high homology to the 
target genes, which could be co-amplified by PCR due to cross-reaction, the predicted 
cDNAs of the target genes were blasted against the zebra fish genome (BlastX). 
Whenever proteins with high homology were found, the corresponding cDNA 
nucleotide sequence was retrieved and aligned with the cDNA of the target gene using 
ClustalX 2.0.9 software. These alignments were further used for specific primer design 
used in the following PCR techniques. 
 
2.4.5 Polymerase Chain Reaction (PCR) 
 
PCR is a process that specifically generates large amounts of DNA in vitro, 
starting from a small amount of a DNA template, with a three-step cycling process. For 
this amplification to occur the essential components for PCR amplification are (1) two 
synthetic oligonucleotide primers, complementary to regions on opposite strands that 
flank the target DNA sequence, and that, after annealing to the template DNA, have 
their 3’ hydroxyl ends oriented toward each other; (2) a target sequence in a DNA 
sample that lies between the pair of primers; (3) a thermostable DNA polymerase that 
can withstand multiple cycles of heating to 95ºC or higher; and (4) the four dNTPs 
(adenine, tyrosine, guanidine and cytosine). 
The first step in the PCR amplification system is the thermal denaturation of 
the DNA sample by raising the temperature to 95ºC. In addition to the template DNA 
this reaction contains a vast molar excess of the two primers. For the second step, 
renaturation or annealing, the temperature of the mixture is slowly cooled to ≈55ºC 
(depending on the primer sequences). During this step, the primers base pair with their 
complementary sequences in the template DNA. In the third step, synthesis or 
extension, the temperature is raised to ≈72ºC, which is optimum for the catalytic 
functioning of Taq DNA polymerase in extending the primers to make copies of the 
DNA template [59]. These three steps are repeated for a number of cycles (usually 20-
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35) and the amount of target DNA duplicates in each cycle, allowing the exponential 
amplification of the amount of specific DNA in the reaction mixture. 
 
2.4.5.1 18S ribosomal (r)RNA PCR  
 
To assess the quality, reliability of the synthesised cDNA (section 2.4.3), the 
step of synthesis was followed by PCR amplification of the gene for the 18S ribosomal 
RNA (18S), which served as an internal control, as it is expressed in abundance in all 
organisms and cell types. 
The reaction mix, for each sample for the 18S PCR was composed of 2.5 µl of 
10x reaction buffer, 0.75 µl of 50 µM MgCl2, 0.1 µl of Taq DNA polymerase 
(5U/µL,EuroTaq, EuroClone® Genomics, UK), 18.35 µl of milliQ water, 0.3 µl of 
dNTPs 10mM each, forward and reverse primers (10 pmol/µl) 1 µl each, and 1 µl of the 
synthesised cDNA (diluted 1:10). 
The primer sequences are indicated in table 2.2:  
 
Table 2.2: Primer sequences for 18S PCR reactions, forward (Fw) and reverse (Rw), previously designed 
by a member of the Molecular and Comparative Endocrinology (MCE) group. 
 
Primer name Sequence (5' →  3') 
18S forward TCAAGAACGAAAGTCGGAGG 
18S reverse GGACATCTAAGGGCATCACA 
 
 
The 18S PCR reaction was carried out in the i-Cycler thermocycler (Bio-Rad) 
and initiated with a denaturation step at 95ºC, 2 min, followed by 25 cycles of 
denaturation (95ºC, 45 seconds), annealing (59ºC, 30 seconds) and synthesis (72ºC, 45 
seconds). A final elongation step was performed at 72 ºC, 1 min. 
PCR products (5 µl) were applied on a 1.5% agarose gel and analysed by 
electrophoresis. 
 
 2.4.5.2 Primer design for target gene cloning  
 
The specificity of the PCR reactions targeting the genes encoding for Tg, TPO, 
TSH, NIS and CtsBa was determined by the design of specific primers for each gene, 
which assured that the amplified sequence matched the gene to be studied. 
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The design of the specific primers for the predicted cDNA sequences acquired in 
section 2.4.4 was performed using the software Primer Premier™ (Biosoft International) 
choosing the primers with less or most instable secondary structures (such as dimers or 
hairpins), low probability of false priming and targeting cDNA in regions with low 
homology to related gene sequences, identified by carrying out sequence alignment. 
Based upon the preceding principles the primers presented on table 2.3 were 
selected. 
 
Table 2.3: cDNA accession numbers acquired from the in silico studies, primer sequences for RT-PCR 
reactions, forward (Fw) and reverse (Rw), complementary to the cDNA sequences of the genes encoding 
for the proteins Tg, CtsBa, TPO, NIS, TSH and GAPDH-2. The amplicon (PCR product) length is 
indicated in base pairs (bp). 
Gene cDNA Accession 
number 
Primers Sequence (5' →  3') Product 
length (bp) 
Fw TCACAGCATCAATGCTGCG Tg DQ278875.1 Rv TGGAGGTTTTTGCGGTTCA 
771 
Fw CTTGGACGGCTGGACATAAC CtsBa BC056688.1 Rv TATAACATTTGATCAGGGGCTTC 
922 
Fw AACCCAAAGGCTGGAACGCTG TPO XM_692744.3 Rv AGAGATGGTGACATGCCCGAAG 
890 
Fw GAATGAGGTTTGGCAGAGGG NIS DQ402039.1 Rv GGTACGGCATGTACTGGTCAGG 
618 
Fw AGACCCTCCAGACAGACATCC TSH AY135147.1 Rv GCGTAGTTGTTCTCCTCGG 
459 
Fw CTTTGGTATTGAGGAGGC GAPDH-2 AY818346 
Rv GGAATGGTCTGGCTTTTCT 
533 
 
The optimization of the PCR reaction conditions was then carried out, by 
choosing the optimal annealing temperature (Ta) and MgCl2 concentration for each pair 
of primers. 
 
2.4.5.3 Optimization of PCR conditions 
 
The choice of Ta is largely determined by the melting temperature (Tm) of the 
two PCR primers [60], estimated by the software. Since the behaviour of new primers 
during a PCR reaction is not well known, a gradient of temperatures was tested. For the 
concentration of MgCl2 needed in the reaction, highly stringent conditions, with 
[MgCl2] =1mM, to medium and low stringent conditions, with [MgCl2] =2-2,5mM, 
were tested, combined with the temperature gradients.  
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After optimization, the final PCR conditions for amplification of the target genes 
were identified and are presented in table 2.4. The PCR conditions selected allowed the 
reaction product to be visualised on an agarose gel and confirmed that the PCR product 
had the expected size and there was only minimal contamination with other reaction 
products (indicated by the presence of additional bands). 
Table 2.4: PCR conditions for the reaction mix and cycling conditions used in the PCR of the different 
target genes. For the reaction mix the values are the volumes in µL for one reaction of 25µL. The DNA 
template was 2µL of cDNA from control fish or 5µL of a PCR product previously obtained from 2µl of 
cDNA using the same PCR conditions (re-amplification, samples marked with *). 
The optimized annealing temperatures (Ta) and number of cycles are shown in the top row of the table. 
The duration (in minutes –’ – or seconds – ’’) of each PCR step (a – first step of denaturation; b- steps of 
cycle repetitions - denaturation, annealing and synthesis; c – elongation step) are also indicated in the 
“PCR steps” panel. 
 
  Tg 
(Ta = 
60,4ºC) 
PCR cycles 
30 
CtsBa 
(Ta = 
59,3ºC) 
PCR cycles 
30 
TPO 
(Ta = 
59,9ºC) 
PCR cycles 
40 
NIS 
(Ta = 
52,0ºC) 
PCR cycles 
30 
TSH 
(Ta= 
63,4ºC) 
PCR cycles 
30 
GAPDH-2 
(Ta= 60,0ºC) 
PCR cycles 
40 
Reaction Buffer  
(160 mM) 2,5 2,5 2,5 2,5 2,5 2,5 
MgCl2  
(50 mM) 1,25 1 1 1 1 0,75 
dNTPs  
(10 mM) 0,5 0,5 0,5 0,5 0,5 0,5 
Primer Fw 
(10 mM) 1 1 1 1 1 1 
Primer Rv 
(10 mM) 1 1 1 1 1 1 
water milliQ st 13,9 13,9 16,9 13,9 13,9 18,15 
cDNA/PCR 
product 5* 5* 2 5* 5* 1 
R
ea
ct
io
n
 
m
ix
 
Taq DNA 
Polymerase 0,1 0,1 0,1 0,1 0,1 0,1 
95ºCa 2’ 2’ 2’ 2’ 2’ 2’ 
95ºCb 30’’ 30’’ 30’’ 30’’ 30’’ 45’’ 
Tab 48’’ 1’15’’ 45’’ 45’’ 45’’ 30’’ 
72ºCb 20’’ 20’’ 30’’ 20’’ 20’’ 45’’ PC
R
 
st
ep
s 
72ºCc 7’ 7’ 5’ 7’ 7’ 7’ 
 
The PCR reaction products were analysed by 1.5% agarose gel electrophoresis 
(5µl) and the size of the amplified bands compared with that predicted from the cDNA 
sequence. For some genes where no visible PCR product was found on the gel, a re-
amplification was carried out using the same PCR conditions and 5µL of the PCR 
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product as template (Table 2.3). Positive PCR products, containing only the reaction 
product of the expected size were cloned into a plasmid cloning vector. 
 
 
2.4.6 Cloning and transformation 
 
Molecular cloning is a process in which a fragment of DNA is inserted in a 
cloning vector (e.g. a plasmid) for subsequent production of many DNA copies 
(propagation) in a host which is usually bacteria [61].  
A plasmid cloning vector is a plasmid which possesses determinant features, 
such as (1) a small size, which is necessary because the efficiencies of transfer of 
exogenous DNA into Escherichia coli (E.coli) decreases significantly with plasmids 
that are more than 15kb long; (2) a choice of unique restriction endonuclease 
recognition sites into which the insert DNA can be cloned (multiple cloning site); (3) 
one or more selectable genetic markers for identifying recipient cells that carry the 
cloning vector-insert DNA construct [59]. 
The recombinant DNA molecules are then introduced into host cells, where they 
replicate, producing large numbers of recombinant DNA molecules that include the 
fragment of DNA originally linked to the vector [61]. The introduction of the construct 
(DNA insert+vector) into the host cells is called transformation. After transformation, 
the exogenous DNA in the host cells can be extracted to be used in future studies. 
 
 
2.4.6.1 Cloning  
 
In the present study the cloning vector chosen was the plasmid pGEM®-T Easy4 
(Promega). This plasmid allows the direct cloning of PCR products with 
3’- deoxyadenosine (A) residues at the extremities as a results of the 5´_3´ exonuclease 
activity of some DNA polymerases, including Taq polymerase. The ends of the PCR 
product are complementary to the 3’- thymidine (T) extremities present at the insertion 
site of the plasmid and greatly improves the efficiency of ligation of the PCR product to 
the plasmid cloning site by the enzyme T4 DNA ligase. The pGEM-T plasmid has its 
                                                 
4
 Vide Annex For plasmid vector map and reference points  
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multiple cloning site within the α-peptide coding region of the enzyme β-galactosidase. 
This enzyme is responsible for X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside) degradation, producing blue coloured colonies of bacteria containing 
the plasmid. Insertional inactivation of the α-peptide allows recombinant bacterial 
clones containing plasmid with an insert to be directly identified by colour on a 
selective plate. The ligation reaction was composed of the reagents and quantities 
presented on table 2.5.  
 
Table 2.5: Reaction components for the ligation of the PCR products of the several genes to the plasmid 
pGEM-T Easy (indicated in volume in µL, in a reaction with 10µL in total). 
 
 
 Tg CtsBa TPO NIS TSH GAPDH-2 
DNA 4,2 8 8 1,5 1,5 4,2 
Enzyme buffer (2x) 
(10x for CtsBa and TPO) 
5 1 1 5 5 5 
pGEM-T Easy 0,3 0,3 0,3 0,3 0,3 0,3 
T4 DNA ligase 0,5 0,5 0,5 0,5 0,5 0,5 R
ea
ct
io
n
 
Co
m
po
n
en
ts
 
(µ
L)
 
Water st - 0,2 0,2 2,7 2,7 - 
 
 
The mixture of the ligation reaction was incubated ON at 4ºC and the product 
used in the transformation of competent cells. 
 
 
2.4.6.2 Transformation  
   
The bacterial cells used in the study were the strain E. coli XL-1 Blue MRF’ 
(Stratagene), treated and aliquoted previously by a member of the Molecular and 
Comparative Endocrinology (MCE) group for competence by the calcium chloride 
method5. Competent cells are those that possess more easily altered cell walls and DNA 
can more readily enter into the bacteria, so these cells readily incorporate foreign DNA.  
 For bacterial transformation, 4 µl of the ligation mix were added to 100 µL of 
competent XL-1 Blue MRF’ cells, and incubated for 30 min on ice. The cells were 
subjected to a thermal shock, 2 min at 42ºC and 2 min on ice, and plated on solid LB 
                                                 
5
 Vide Annex for calcium chloride competence method protocol 
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selective medium6, with 75µg of ampicilin/mL, 80 µg/ml X-Gal and 0.5 mM isopropyl-
beta-D-thiogalactopyranoside (IPTG), and allowed to grow ON at 37ºC. 
 After the incubation the plates were analysed and the number of white colonies 
(with the insert) and blue colonies (without insert) evaluated. 
  
2.4.6.3 Plasmid DNA extraction (Minipreps) 
 
For plasmid DNA (pDNA) extraction from recombinant bacteria the method of 
alkaline lysis was applied. In this method the addition of an alkaline solution (sodium 
hydroxide, NaOH) and a detergent (sodium dodecyl sulphate, SDS), disrupts the cell 
wall, dissolves the cell membrane, thus releasing the genetic material of interest to the 
solution. 
  
To obtain the purified pDNA, some white colonies from section 2.4.6.2 were 
transferred and allowed to grow in approximately 2 mL of LB Broth with 100 µg/ml 
ampicilin, ON at 37ºC with agitation. 
1.5 ml of culture were transferred into a fresh tube and centrifuged in a 
microcentrifuge at room temperature and maximum speed for 5 min. The supernatant 
was discarded and the pellet resuspended with 100 µl of cold GTE 1x, with RNase7 
(final concentration: 50µg/ml). 200 µl NaOH 0.2 M/SDS 1%8 were added and mixed by 
inversion and kept on ice until clarified. The solution was neutralized by adding 150 µl 
of cold potassium acetate (KAc)9 3M, pH 4.8 followed by mixing until flocculation. 
The tubes were incubated on ice for 15 min, and centrifuged maximum speed for 15 
min at 4ºC. The supernatant was collected into a fresh tube, 1 volume of cold 
isopropanol 100% was added and incubated at -20ºC for 20 min, following 
centrifugation at maximum speed for 20 min, 4ºC. The supernatant was discarded and 
the DNA pellet washed twice with cold ethanol 75%. The sample was left to dry and 
resuspended in milliQ water. 
 
                                                 
6
 Vide Annex For LB medium preparation 
7
 Vide Annex for GTE 1x with RNase solution preparation 
8
 Vide Annex for NAOH 0.2M/SDS 1% solution preparation 
9
 Vide Annex for KAc 3M, pH 4.8 solution preparation 
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 The purified and resuspended pDNA was digested with restriction enzymes to 
liberate the insert and confirm if the plasmid was successfully ligated with a PCR 
fragment of the expected size. The enzyme used was chosen according to the restriction 
sites of the plasmid10 and the insert sequence, so that the insert would not be cleaved. 
The enzymatic reaction mix utilised is described in table 2.6: 
 
Table 2.6: Reagents for the enzymatic digestion of pDNA (insert isolation) containing each target gene 
indicated in µl per digestion (EcoRI and SalI from Promega). 
 
 Tg CtsBa TPO NIS TSH GAPDH-2 
pDNA 4 4 1 4 7 1 
OPA buffer11 2 2 2 2 2 2 
Enzyme EcoR I  EcoR I  EcoR I  EcoR I  EcoR I  SalI 
Enzyme volume (µL) 0.5 0.5 0.5 0.5 0.5 0.5 
sterile water 3.5 3.5 6.5 3.5 0.5 6.5 
 
 The reaction was incubated at 37ºC for 1,5 hours, and digestion products were 
visualized by (1%) agarose gel electrophoresis. 
 
 The minipreps (pDNA) containing the DNA fragment with the expected size for 
each target gene were sequenced at CCMar sequencing facilities using T7 and SP6 
primers, to confirm their identity. 
 
 
 2.4.7 Real-Time PCR 
 
 Real-time reverse transcription quantitative PCR (or qPCR) is an established 
technique for gene-expression analysis. Benefits of this procedure include its sensitivity, 
large dynamic range as well as accurate quantification of specific gene expression [62].  
The assay relies on the detection of fluorescent marker which binds to the DNA 
[63] and the measurement of the increase in the fluorescent signal, which is  
proportional to the amount of DNA produced during each PCR cycle [64], which 
increases in an exponential like manner during the course of the reaction (fig 2.1).  
                                                 
10
 Vide Annex  For plasmid vector map and reference points 
11
 Vide Annex for OPA buffer preparation 
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Fig 2.1: The fluorescence signal increase throughout the PCR cycles due to the DNA amplification.  
 
Two main types of detection chemistry are most used:  TaqMan® probes and 
the SYBR Green dye. The latter system was used for qPCR in the study. When 
TaqMan probes are used, primers and probes specific for the sequence of interest are 
added into the reaction mixture. This probe is marked with a fluorophore, which does 
not emit any fluorescence while it is attached. As the extension steps occur, the probe is 
broken down, the fluorophore released and it starts to emit fluorescence (Fig 2.2). So, 
only specific products to which the probe binds are detected after amplification. 
The SYBR Green is not as specific as TaqMan as it emits fluorescence when it 
binds to any double stranded DNA present in the reaction (Fig 2.2). Nevertheless, it 
does not require the purchase of expensive fluorescent probes for each gene (adequate 
when we want to quantify several genes in a small number of samples) and it allows 
characterisation of non-specific amplification by melting curve analysis. 
   
 
Fig 2.2: Schematic representation of the functioning of the SYBR Green dye and TaqMan probe. SYBR 
Green binds to the dsDNA as it is being synthesised, and starts to emit fluorescence. The TaqMan 
probe binds to the DNA with the primers and as the fluorophore (green) is excited, it transfers the energy 
to a quencher molecule (orange) present in the probe; as the extension occurs, the probe is broken down, 
the fluorophore is released emitting fluorescence. Taken from [65]. 
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Individual reactions are characterized by the PCR cycle at which fluorescence 
first rises above a threshold background fluorescence (set by the user or auto-calculated 
by the software), a parameter known as the threshold cycle (CT). The more target there 
is in the starting material, the lower the CT (fig. 2.3). This correlation between 
fluorescence and amount of amplified product permits accurate quantification over a 
wide dynamic range, while retaining the specificity of conventional end-point PCR 
assays, but with a greatly increased sensitivity [64]. 
 
Fig 2.3: Comparison of fluorescence between two amplification plots for the same amplicon, with 
CTa = 17 and CTb = 22. The difference between the samples CT is due to the fact that sample b has less 
starting material (sample b = 1:10 sample a). The horizontal line (orange) is the threshold of the reaction. 
 
 A standard curve is obtained by running qPCR reactions of a dilution series of a 
template containing the fragment of interest, such as a linearised miniprep or cDNA. 
This standard curve can be used to relate the quantity of amplicon amplified from a 
known concentration of starting material to a given CT, which is a linear relation over a 
great magnitude of starting quantity. To determine the starting amount of the target gene 
in the cDNA samples analysed, their CT obtained by qPCR is related to a concentration 
value obtained from the standard curve which is run in the same plate as the cDNAs.   
 
 Normalising to a reference gene is a simple and popular method for internally 
controlling for error in qPCR [62], such as the amount of starting material and variation 
of reverse transcription efficiencies [66].  
 A vast number of reference genes have been proposed for gene expression 
analysis. Among the most common used housekeeping genes are β-actin, 
glyceraldehyde-3-phophate dehydrogenase (GAPDH) and 18S rRNA, as they are 
expressed constitutively and are involved in basic housekeeping functions required for 
cell maintenance [67], and their expression is assumed to be unaffected by most 
experimental parameters [68]. However, it is now generally accepted that there is no 
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universal reference genes and that the reference genes (ideally more than one) must be 
validated for particular experimental conditions [69]. The candidate genes evaluated 
were 18S and the mRNA for GAPDH testis-specific (GAPDH-2), which are commonly 
used as internal reference genes in qPCR [62].  
 For the application of the qPCR technique to the present study to evaluate the 
level of target gene expression, the preparation process was very similar to that 
described for the PCR technique and included the design of specific primers for each 
gene and the optimization of reaction conditions (in this case temperature). 
 
 
2.4.7.1 Primer design 
 
 Novel gene specific primers were designed with the software Beacon Designer 
(PREMIER, Biosoft International). The sequences analysed for the design of qPCR 
primers were those identified in silico (section 2.4.4) and limited by the primers used to 
obtain the cloned fragments (section 2.4.5.2). 
 Other factors taken into consideration in the design of these primers were: 
- avoid runs of 4 of more bases, as it would reduce annealing efficiency; 
- include some G/C clamps in the 3’ extremity, as it facilitates the binding of the 
primer to the template; 
- keep G/C percentage in the primers around 40 to 60%; 
- avoid complementary sequences between the primers, to reduce the occurrence 
of secondary sequences such as hairpins, self dimers and cross-dimers; 
- keep the amplicon size short (75-150 bp); 
- design forward and reverse primers in a different exon or one of the primers, to 
the junction of two exons, so that amplification from gDNA (if there is 
contamination) is reduced or distinguishable by size from cDNA amplification.    
- Design primers based on the alignment of the target cDNAs with cDNAs from 
related proteins, to avoid cross-amplification  
 
Taking into account the previous considerations the following primers (Table 2.7) 
were designed: 
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Table 2.7: Sequences for forward (Fw) and reverse (Rw) primers designed for qPCR using Beacon 
Designer (Premier, Biosoft International), complementary to the cDNA sequences of the genes encoding 
for the proteins Tg, CtsBa, TPO, NIS and TSH, GAPDH-2 and 18S. The amplicon (or product) length in 
base pairs (bp) is indicated (Primer for 18S was previously designed by a MCE group member). 
Gene cDNA Accession Number Primer sequences (5' →  3') 
Product 
length (bp) 
Fw TCATCAGCAGAGCCAAGAACATCAAG Tg DQ278875.1 
Rv ATCCTGAAGGTGTGGGCGAGTG 
177 
Fw CCGTCTGCTGCTTGGGATTTCTGG CtsBa BC056688.1 
Rv TGCTTCACAGGGTTCAATGGTATATGGAC 
104 
Fw CCAGCCAGACCTCGTTC TPO XM_692744.3 
Rv CGGAGATGAGCGGAAGAAG 
140 
Fw TTTGCGATAGACCCTCAGAG NIS DQ402039.1 
Rv GCTCACAATCAGACACAGAC 
183 
Fw TGGTGGGTCCTCGTTTTATTGTTCAG TSH AY135147.1 
Rv GCGGGTTCTAAGGGCACATTCATC 
179 
Fw CTGTGGGCAAAGTCATTCCTG 
GAPDH-2 AY818346 
Rv ACTCCTTGATGTTGGCGTAGC 
135 
Fw CGATCAGATACCGTCGTAGTTC 18 S 
 
Rv CCCTTCCGTCAATTCCTTTA 
 
 
 
2.4.7.2 qPCR reactions 
 
The qPCR reactions (20µl) were performed for each sample in duplicate 
reactions with 10 µl of Power SYBR® Green PCR Master Mix (2x) (Applied 
Biosystems, UK), 0,2 µl of each specific primer, Fw and Rv (10 µM), 2 µl of the cDNA 
template (diluted 1:10) and 7.6 µl of sterile milliQ water. In the case of TSH and TPO 
target genes, for which a lower gene expression (higher Ct) was detected, the qPCR 
reactions were carried out using non-diluted cDNA for each individual. The qPCR 
reaction in the Bio-Rad iClycler iQ5 qPCR thermocycler was initiated at 95ºC for 10 
min for enzymatic activation, followed by 55 cycles of denaturation (95ºC, 30 seconds), 
annealing (Ta, 20 seconds) and synthesis (72ºC, 30 seconds).  
After the synthesis cycles ended the melting curve was carried out by a 
progressive increase of the temperature in a total of 75 cycles, starting at 60 ºC for 10 
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min and increasing each cycle by 0.5 ºC, in order to separate PCR products by their 
melting curve and allow the detection of non specific products and dimers. 
 
 
2.4.7.3 qPCR optimizations 
 
For successful results using this molecular tool, a series of steps were needed 
before performing the final reactions as described in the previous section (2.4.7.2). 
It was first necessary to optimize the Ta for each pair of primers, the sample 
cDNA dilutions and to prepare the miniprep dilution series used in the standard curves. 
 
 
a) Ta optimization 
 
Although in the normal PCR reactions several factors may be manipulated to 
achieve optimal amplification conditions, in the qPCR reactions the only parameter that 
was manipulated was the temperature.  
The same cDNA was used to optimize all pairs of primers (a mix of cDNAs 
from the control group, diluted 1:10), by testing its amplification through a temperature 
gradient based on the Ta suggested by the software of primer design. An optimal 
temperature of 60ºC was chosen for all primer pairs (the temperature obtaining a lower 
threshold cycle and a higher fluorescence level for the same cDNA).  
 
 
b) Standard preparation 
 
 The preparation of the standards consisted of linearization of pDNA so that its 
structure would be as similar as possible to the cDNA (see section 2.4.3), followed by 
its purification and quantification. 
To linearise the minipreps, a restriction enzyme cutting at a unique site was 
chosen for each target by restriction analysis using the software Webcutter 2.0 
(freeware [70]) genes, and following two rules: the restriction enzyme had to cut the 
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plasmid only once and it could not cut inside the insert sequence. The enzymes chosen 
and the enzyme reaction components were as presented in table 2.8. 
 
Table 2.8: Enzymes and the enzyme reaction components in µl used for the linearization of the different 
pDNA to be used for the standard curve of each gene in qPCR. Enzymes and buffers were purchased 
from Promega (D, H or MC=Multi Core). 
 
 Tg CtsBa TPO NIS TSH GAPDH-2 
pDNA (µl) 8 8 6 8 8 6 
Buffer D MC H MC MC H 
Buffer 10x 
volume (µl) 
4 4 4 4 4 4 
Enzyme SalI ApaI PstI ApaI ApaI PstI 
Enzyme 
volume (µl) 
1.5 1.5 1.5 1.5 1.5 1.5 
st water (µl) 26.5 26.5 28.5 26.5 26.5 28.5 
 
 
Samples were incubated at 37 ºC for 1.5h. As the electrophoresis results 
confirmed the successful digestion by analysis of a small aliquot of digestion product 
(2 µl), the remainder of the linearised pDNA was purified using Illustra GFX PCR DNA 
and Gel Band Purification kit (GE Healthcare) according to manufactures instructions. 
For the purification of linearised pDNA, 500 µL of Capture buffer were added to 
the samples. The mixture was loaded onto a purification column placed in a collection 
tube and centrifuged at room temperature in a microcentrifuge at maximum speed for 
30 sec. The flow-through was discarded and wash buffer added to the column followed 
by another centrifuge step for 30 sec. The collection tube was discarded and the column 
transferred to a fresh DNase-free tube. 40 µl of Elution buffer were placed in the centre 
of the membrane, incubated at room temperature, 1 min, and centrifuged at room 
temperature, maximum speed for 1 min.  
 
The linearised pDNA was quantified by preparing Quant-iT™ working solution 
obtained with a 1:200 diluting of Quant-iT™ dsDNA HS reagent in Quant-iT™ dsDNA 
HS buffer. Once the working solution was prepared, 1 µl of the samples (1:100 
linearised pDNA) and 10 µl of each standard (standard 1 and 2) were loaded into assay 
tubes to which 199 µl and 190 µl of working solution were added, respectively. The 
 40 
Qubit™ fluorometer was calibrated with the prepared standards followed by the reading 
of the samples concentrations. 
 
 
c) Sample dilutions optimization 
 
The standard curve was attained through the duplicate of serial dilutions, 10-fold 
dilutions from 0.5 ng/µl to 5.0 ag/µl, of the linearised pDNA containing the cloned 
target gene, and the mean used to calculate efficiency of the qPCR reaction. 
The sample dilution test with cDNA dilutions also in duplicate from 1:5 to 
1:3125 served to verify if the number of transcripts of each gene fit in the linear part of 
the standard curve and also to analyse the qPCR efficiency. 
 
 
2.4.7.4 Normalization 
 
The genes 18S and GAPDH-2 were tested for housekeeping genes using optimized 
primers (table 2.6) and temperature (Ta = 60.0ºC). After validation GAPDH-2 was used 
for samples normalization, as it presented no significant differences in expression 
between groups. Then, the mean amount obtained for each gene in each cDNA was 
divided by the mean absolute value obtained for GAPDH-2, quantified following the 
same procedure as the target genes.  
 
 
2.5 Statistical Analysis 
 
Statistical analyses of the results from the morphological and molecular analysis 
were performed using the software SigmaStat. 
The results from the morphological analysis were submitted to One Way 
ANOVA and Tukey-test with the log10 of the variable (internal area, external area and 
thyrocyte height). 
In respect to the results of the qPCR, the validation of 18S and GAPDH-2 was 
achieved by a One Way ANOVA and Tukey-test of the variable (Starting quantity). The 
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normalized results of the genes CtsBa, Tg, TPO, TSH and NIS were also submitted to 
One Way ANOVA and Tukey-test with the log10 of the variable (relative expression). 
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3. Results  
 
 By using a series of tools, morphological and molecular, such as PCR and 
qPCR, a number of results were attained during the practical work.  
 By the end of the 21 days of the experiment, an apparent behavioural change in 
the fishes treated with the bactericide TCS was detected. These animals had a different 
swimming pattern from the control animals and from the ones treated with PTU, but 
additional behaviour studies would be necessary to confirm this. 
The final mean weight and length and associated standard error (S.E.M) for each 
group were those presented on table 3.1. 
Table 3.1: Mean body weight (g) and length (cm) (± SEM) for the different treatment groups after the 21 
days exposure to the treatments for n=8. 
Tank Mean body weight (g) Mean length (cm) 
Control 1 0.473 ± 0.04 2.938 ± 0.05 
Control 2 0.532 ± 0.04 2.877 ± 0.07 
PTU 1 0.424 ± 0.02 2.820 ± 0.06 
PTU 2 0.460 ± 0.05 2.946 ± 0.10 
TCS 1 0.484 ± 0.02 2.876 ± 0.05 
TCS 2 0.566 ± 0.03 3.025 ± 0.05 
 
 
3.1 Histological results 
 
 The thyroid tissue was examined in 8 individuals per experimental group 
ensuring that approximately the same area was surveyed in each individual. The 
diagram in fig 3.1A represents the region selected for analysis of thyroid follicles which 
were clustered around the aorta and the heart was evident in the section. Clear 
differences were observed in the appearance of the thyroid tissue stained with 
Cleveland-Wolfe trichrome prepared from different treatment groups (fig 3.1B). The 
staining method permitted easy identification of the thyroid follicles in histological 
sections and the colloid and lining thyrocytes were readily differentiated. For example, 
when simple stereology was applied the TCS group was found to have a higher number 
of follicles which were also bigger than those found in control fish. In contrast, the PTU 
group had a lower number of follicles than control fish. In addition, analysis at a high 
magnification revealed that the thyroid follicle epithelium was thinner in both TCS and 
PTU treated fish compared to the control fish.  
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Fig 3.1: Thyroid tissue histology in treated and control fish. A – Scheme (photoshop rendered of a low 
magnification photograph) of the region in which the thyroid follicles were observed. Sections were 
prepared and stained with Cleveland-Wolfe trichrome and when the aorta was visible and the heart 
evident follicles were analysed in the relevant sections. The scale bar corresponds to 500 µm). B - 
Thyroid tissue stained with Cleveland-Wolfe trichrome from the different treatment groups, (a) - control, 
(b) - PTU and (c) - TCS, Note the orange staining colloid (3) in the centre of thyroid follicles (2) which 
are distributed in connective tissue surrounding the aorta (1). The thyrocytes (4) are evident as a layer of 
cells surrounding the colloid and isolate the follicle lumen from the surrounding tissue. The scale bar 
corresponds to 100 µm. 
 
In order to obtain a quantitative comparison for the morphology of the thyroid 
tissue in the experimental groups stereology was carried out. Follicle internal and 
external areas as well as the thyrocyte height were measured in 4 different individuals 
on 6 sections and the results obtained were compared.   
The mean area of the follicle lumen (internal and external) and mean thyrocyte 
height and S.E.M for the different treatments are presented in fig 3.2. Considerable 
variability in the area of the follicle lumen occurred in all groups and large and small 
follicles were evident in all of the experimental groups (fig 3.1 B). However, in general 
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the mean internal area of thyroid follicles was greater in the group of fish treated with 
TCS (6606±2405 µm2) compared to the control (1913±621 µm2) and PTU (2386±637 
µm2) treated fish. Concerning the mean external area, the TCS group stands out as the 
group with a higher mean value (7165±2485 µm2) when compared to the control 
(2417±730 µm2) and PTU (2791±674 µm2) groups. 
To evaluate if the differences observed between the groups were significant, data 
were then subjected to statistical analysis (One Way ANOVA) after 
log10 transformation of each variable. A significant statistical difference among groups 
(P = 0.035) was detected for the internal area measurements, and using Tukey test for 
pairwise comparison between groups, a statistical significant difference (P = 0.05) was 
detected between the TCS and the control groups. The same type of statistical analysis 
detected statistically significant differences (P = 0.05) in the follicle external areas 
between groups (fig 3.2), with the TCS group being significantly greater than the 
control and PTU groups which did not differ significantly. 
 A difference in the mean thyrocyte height was also observed between groups, 
with highest values found for the control group (2.77±0.198 µm) followed by the PTU 
(1.708±0.0728 µm) and TCS (1.618±0.0733 µm) groups (fig 3.2). Statistically 
significant differences between the height of thyrocytes between groups (P < 0.001) 
were confirmed by One-way ANOVA. This test was followed by a Tukey test, 
indicating statistically significant differences existed between TCS vs Control and PTU 
vs Control (both with P < 0.001). 
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Fig 3.2: Graphical representation of the mean + SEM of thyroid follicle internal/ external areas (µm2) and 
mean thyrocyte heights (µm) determined for fish treated for 21 days with the goitrogen PTU (n = 4), TCS 
(n = 6) and control (n = 4). The different letters (a and b) indicate statistically significant differences exist 
between groups in each panel. 
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3.2 Molecular Results 
 
 As a complement to the histological and stereological analysis molecular 
analysis of specific gene expression was assessed by qRT-PCR. The genes selected for 
analysis were those encoding proteins known to be of key importance in THs 
biosynthesis in the thyroid follicle. The analysis was conducted with whole-heads of 
zebrafish, ensuring that the thyroid tissue was present and the effect of exposure to test 
chemicals was evaluated by measuring their mRNA expression. 
 
3.2.1 Tissue gene expression 
 
In order to confirm the gene expression and relative expression levels of the 
genes in study in the head of zebra fish, RT-PCR reactions were performed with 
specific primers (cloning, see table 2.1, methods) for each gene in optimized conditions 
(see table 2.3, methods,) . Bands of the expected size were obtained by RT-PCR for all 
the genes of interest (figure 3.4), as expected, confirming their expression in the tissues 
from which the RNA was extracted. These cDNA fragments were then cloned and 
sequence analysis used to confirm their identity. 
 
 
Fig 3.2: RT-PCR products with gene specific primers from zebrafish cDNA (head) in 1.5% agarose gel 
stained with ethidium bromide, using optimized conditions. The amplified genes were (a) 
TPO - Ta = 60ºC, [MgCl2] =1mM and 40 cycles; (b) CtsBa - Ta = 59,3ºC, [MgCl2] =2mM and 30 cycles;  
(c) NIS - Ta = 52ºC, [MgCl2] =2,5mM and 30 cycles, (d) TSH - Ta = 63,4ºC, [MgCl2] =2mM and 30 
cycles and (e) Tg - Ta = 60,4ºC, [MgCl2] =2mM and 30 cycles  and (f) GAPDH-2 - Ta = 60ºC, [MgCl2] 
=1mM and 40 cycles. Sizes of the bands were compared with the sizes of the 1 Kb Plus DNA Ladder 
(Invitrogen) (M), which are indicated in base pairs (bp) in the left panel. For the genes CtsBa and NIS, (b 
and c) the PCR reactions resulted on several fragments; the fragments with the expected size are the most 
intense and are signalled with the arrow head.     
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3.2.2 Validation of internal reference genes for qRT-PCR and 
assay characterization  
 
qRT-PCR efficiency was determined using the relative standard curve method 
with serial dilutions of the cloned and sequenced cDNAs for the desired gene and with a 
cDNA dilution series (from 1:5 to 1:3125) of control samples for the target genes 
(table 3.1). cDNA dilutions 1:10 were also used for the specific real-time primers and 
provided a first approach to establish the Ct values of each gene (table 3.1).  
 Table 3.2: qRT-PCR efficiencies for the different genes determined for the standard curve (with dilution 
series from 0.5 ng/µl to 0.5 fg/µl of cloned cDNA) and for the cDNA dilution series (1:5 to 1:3125). Ct 
values for the control cDNA for an automatically defined threshold.  
  qRT-PCR efficiency (%) 
Gene CT                  (cDNA dilution 1:10) 
Standard 
curve 
r2 cDNA r2 
Tg 25 88,7 0,998 81,4 0,998 
CtsBa 26 104,1 0,999 112,3 0,987 
TPO 31 91,8 0,999 94,4 0,999 
TSH 31 96,2 0,999 72,4 0,998 
NIS 32 94,2 0,979 101,4 0,965 
18S 13 85,6 0,995 79,9 0,977 
GAPDH-2 25 83,4 0,998 104,9 0,999 
 
  
The amplification efficiencies for qRT-PCR were, in general, within the 
recommended values for a good and sensitive quantification (efficiency higher than 
80% and R2>0,985 [71]). Most of the target genes gave a similar efficiency for 
amplification with cDNA as the template and in standard dilutions of linearised cloned 
cDNAs. However, in some cases, such as TSH, the amplification efficiency was lower 
when cDNAs generated from tissue were used. This may have been caused by the very 
low amount of material in the samples applied in the reactions (as is the case of TSH) or 
by the sample with the higher dilution factor from the cDNA dilution series that with a 
very weak signal (in 18S), affected the overall efficiency. The Ct values obtained for a 
1:10 dilution of control cDNA was used to give a first indication of the level of 
expression of each gene and formed the basis of the selection of the dilutions for use in 
quantification. It was decided to use for sample quantification a 10 fold dilution for 
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most of the genes, with moderate to high genes expression (eg. Tg, CtsBa, TPO and 
GAPDH-2), and to use non-diluted cDNAs in the quantification of NIS and TSH, 
because of their lower gene expression (reflected by their higher Ct values). 
 
3.2.2.1 Reference gene validation 
 
 In this work the genes 18S and GADPH-2 were assessed as possible reference 
genes prior to their application. The level of expression of each gene was evaluated 
between the treatment groups, using cDNA synthesised from equal amounts of RNA 
extracted from experimental animals to be used for qRT-PCR. For validation, the 
starting quantity (SQ) for each gene was submitted to a One Way ANOVA test 
followed by a Tukey test if possible (fig 3.5). Analysis of the results revealed that the 
gene 18S was unsuitable for use as a reference gene as it presented statistical significant 
differences in the mean SQ between the control (0.153 ± 0.026 ng) and TCS 
(0.034 ± 0.0073 ng) groups (fig 3.5). The mean SQ of the PTU group 
(0.095 ± 0.018 ng) presented no statistical significant differences from the remaining 
groups.  
For GAPDH-2, fig 3.5, no statistical significant differences between the groups 
control (2.34x10-5± 6.25x10-6 ng), PTU (2.48x10-5 ± 6.98x10-6 ng) and TCS 
(1.54x10-5 ± 1.20x10-6 ng) were found, and although a small apparent decrease is 
observed in the TCS group. Thus, the gene GAPDH-2 was validated as a reference gene 
for the qPCR results normalization. 
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Fig 3.3: Mean starting quantities (ng) for 18S and GAPDH-2 genes for the different treatments (Control 
n =5, PTU n = 6 and TCS n = 5). The different letters (a and b) are indicative of significant statistical 
differences (P <0.05) between the treatment groups, evaluated by a One Way ANOVA of the variable, 
followed (for 18S) by a Tukey test. 
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3.2.2.2 Changes in Gene Expression 
 
The expression of each of the genes was then quantified in the individual 
samples of zebrafish heads under the different treatments using optimized qRT-PCR 
conditions (see section 2.4.7.2). The relative expression for the different samples and 
different genes was calculated by the ratio between the starting quantities obtained for 
the gene of interest and for the validated reference gene, GAPDH-2. Group means for 
the relative expression of all genes analysed are presented in fig. 3.6. A statistically 
significant difference (P <0.05) was found in the expression of TSH in the control 
(5.16x10-4±1.74x10-4) versus the TCS (2.29x10-3±8.86x10-4) and PTU 
(2.00x10-3±5.43x10-4) treated fish, and in the latter groups it was significantly increased 
(p<0.05). The high levels of TSH observed in the PTU group are in agreement with 
induced hypothyroidism, where lower THs in circulation increases the level of 
expression of TSH. These results are as expected for the PTU group as this drug is 
known to inhibit intrathyroidal synthesis of thyroid hormones (by influencing TPO 
activity) and blocks the peripheral conversion of T4 to T3, thus lowering THs levels.  
 The level of expression of the gene NIS in the TCS group was also significantly 
different (P <0.05) from the control fish or those treated with PTU. For this gene, the 
TCS exposed fish had a higher level of relative expression (3.52x10-3±6.57x10-4) than 
the control (1.61x10-3±4.42x10-4) and PTU (1.98x10-3±2.10x10-4) groups. 
Analysing the relative expression dispersion in fig. 3.6 (dots), it can be noticed, 
an internal variability in gene expression in some of the treatment groups. In the results 
for TPO relative expression, the control group revealed high data dispersion indicating 
variable expression relative to the treated fish. Of all the remaining genes analysed, the 
highest variability of expression was found in the TCS exposed fish. 
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Fig 3.4: Dispersion (dots) and mean relative expression (gray bars) of the several genes analysed (Tg, 
TSH, TPO, NIS and CtsBa) normalized with GAPDH-2 (SQ gene/SQ GADPH-2) for the treatments 
control (n = 5), PTU (n = 6) and TCS (n =5) and respective SEM (bars). The different letters (a and b) are 
indicative of significant statistical differences (P <0.05) between the treatment groups, evaluated by a One 
Way ANOVA of the log10 variable, followed by a Tukey test for TSH and NIS. 
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4. Discussion 
 
The antimicrobial agent TCS, widely used in consumer products, is now an 
established environmental contaminant [72]. Although it is known from the work by 
Crofton et al that TCS decreases the level of THs in circulation in mice [47], its effects 
at the level of thyroid hormone synthesis are not known. The results in the present thesis 
indicate that TCS leads to morphological changes in the thyroid tissue, such as follicle 
size increase and decreased thyrocyte height in a fish model, the zebrafish. The effects 
of TCS on the thyroid tissue were also found at the gene expression level. The TSH and 
NIS genes presented expression levels significantly higher for the TCS group than those 
observed for the control group, in zebra fish head. For the remaining genes analysed 
(Tg, TPO, and CtsBa), apparent differences were observed compared to the control 
group, but did not reach statistical significance because of the spread of the data in the 
treatment group. The final results for the group treated with PTU, here used as a 
positive control since it is a goitrogens whose effects are most studied; indicate 
morphological alterations, with the reduction of thyrocyte height, as well as changes in 
the levels of gene expression. In PTU treated fish the TSH gene presented significant 
increase in expression while the remaining genes were not changed.   
Since the exposure to some drugs (therapeutic or industrial pollutants) in high 
quantities may cause goitrous hypothyroidism [8] and has been described mainly in 
mammals and is diagnosed by low circulating TH concentrations with enlargement of 
the thyroid tissue. In the present study the thyroid activity of zebrafish exposed to TCS 
and PTU was evaluated by histological and stereological analysis, in order to assess the 
effects of these drugs. 
It has been described that inactive thyroid tissue possess flat cells (thyrocytes) 
lining the follicles and, in contrast, active follicles present cuboidal thyrocytes [73]. The 
observations of zebrafish thyroid tissue (fig 3.1 B) in the present work suggest that the 
individuals exposed to TCS and PTU presented inactive thyroid follicles. Our 
stereological analysis confirmed that a significant reduction in the follicle thyrocyte 
height in the PTU and TCS groups occurred (fig 3.2), indicating the inactive state of the 
follicles.   
The histological and stereological results of the tissues from individuals treated 
with TCS presented the most significant changes. Alterations in thyrocyte height and 
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mean follicle areas (internal and external) were found to be lower and higher, 
respectively, when compared with the control group (fig 3.2). The increase in follicle 
areas is due to colloid accumulation and is also described as a characteristic of 
hypothyroidism [73]. Results in the thyroid tissue from the zebrafish treated with PTU, 
indicative of thyroid inactivation, are also in accordance with a situation of 
hypothyroidism, as described by Villar et al for PTU-treated goats [52]. van der Ven et 
al also described the reduction of THs in the circulation in adult zebrafish exposed to 
PTU [23] indicating hypothyroidism was induced. In our PTU treatment group no 
significant increase in follicle area was observed. Results were different from the 
observations of Yi et al, in rat, where the follicular colloid increased with the 
administration of PTU [51] and from van der Ven et al who observed an increase in 
follicle activity in juvenile zebrafish [23]. 
A reduction of THs in the circulation in response to TCS treatment has been 
previously reported in rats [47]. Although it was not possible to measure the TH levels 
in this study, due to the small size of fish, the data acquired strongly suggest that TCS 
affects TH synthesis, causing hypothyroidism, as evidenced by histological and gene 
expression changes characteristic of this status.  
The expression analysis of the mRNA levels of key genes related to TH 
synthesis was performed using quantitative RT-PCR technique, using the relative 
standard curve method with normalization to a reference gene. With this approach the 
errors (differences in mRNA input or RT-efficiencies between samples) possibly 
introduced in the steps performed prior to qRT-PCR are controlled [62]. 
However, the choice of reference or internal control genes is not consensual. 
While many studies use only one reference gene, it has been suggested (Vandesompele 
et al) that this approach leads to relatively large errors and that accurate normalization 
can only be attained by carefully selecting multiple reference genes for each particular 
experiment or system [69]. In this study, the normalization of the expression of the 
genes of interest was performed using GAPDH-2, which in our validation assay 
(fig 3.3) presented no statistically significant differences between the treatment and 
control fish, using samples synthesised from the same amount of RNA.  Our results in 
GADPH-2 expression were found to be in accordance to the work from Manchado et al, 
where expression levels in Senegalese sole larvae remained unaltered even when 
animals are exposed to a blocking agent of THs synthesis (thiourea) [74]. 
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The gene 18S rRNA was also evaluated as reference gene, since it is one of the 
most frequently used reference gene which is found to be invariant in many biological 
situations [62]. However, after validation it was detected that its gene expression had a 
significant variation between the groups (fig 3.3), thus making the gene inadequate for 
this study.  
This validation results suggest that the goitrogen treatment is somehow affecting 
protein synthesis, as the expression of the 18S rRNA (a ribosome unit) is significantly 
reduced in the TCS-treated group, while the glycolitic processes are probably not 
significantly affected by the treatment (GAPDH-2 levels are not significantly affected).  
 For each gene analysed, some variability of response between the animals of the 
same group can be observed (fig 3.4, dispersion graphs) making possible the detection 
of some extreme responses in some of the animals, while in others the expression levels 
are unaltered. The observed variability may be due to variability between the 
responsiveness of individual fish, which could be reduced by increasing the number of 
fish tested, or to differences in the dose consumed (orally) by the different fish.  
The expression of the key genes involved in TH synthesis (Tg, TSH, TPO, NIS 
and CtsBa) was analysed in whole zebrafish heads, which was considered to be a good 
approximation to their expression in the thyroid tissue (difficult to isolate due to small 
fish size and dispersed characteristic of thyroid tissue in fish) since the expression of 
most of these genes are thyroid (Tg, NIS, TPO) and pituitary-specific (TSH) [10]. Only 
CtsB is not thyroid specific but possesses an important role in colloid solubilisation. In 
the absence of CtsB there was a reduction in T4 circulating levels in mice [22]. 
When analysing the mRNA relative expression results (fig 3.4), significant 
increases in the TSH (in both treatments) and NIS (only in the TCS treatment) levels 
can be observed. For the genes Tg, TPO and CtsBa, slight variations were detected 
which were not statistically significance between treatment and control fish.  
Pituitary TSH synthesis is known to be regulated by the TH levels, and their 
circulating levels in turn regulate THs synthesis and liberation (HPT axis). 
Pradet-Balade et al have studied the relation between THs and TSH mRNA levels in 
vivo in the turbot. For diminished levels of T4, TSH levels were increased [75]. These 
conditions were representative of hypothyroidism and demonstrated that THs regulate 
TSH by negative feedback in order to maintain THs levels constant.   
In this study, the TSH gene relative expression in zebrafish heads increased in 
the treatment with PTU. This drug is known to interfere with the normal functioning of 
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the enzyme TPO and to inhibit peripheral conversion of T4 into T3 [8]. In previous 
studies in goat and rats, PTU was shown to induce hypothyroidism, by the observed 
reduction of circulating T4 levels. In the study by Hood et al, T4 reduction was 
accompanied by an increase in TSH levels [47, 76].  
In our experiment, the TSH relative expression was also significantly increased 
in the TCS group when compared to the control. It is known from the work by Crofton 
et al, in mice, that T4 levels were reduced for animals treated with TCS [47], at the same 
TCS dosage used in this thesis. Considering these results and previous work on the 
effects of PTU, the fact that TCS was able to induce an increase in TSH gene expression 
suggest that this compound may also have caused a reduction in TH circulating levels 
and a consequent increase in TSH mRNA and protein production and release, in order 
to restore TH levels. However, further work is needed to confirm this observation.  
TSH levels are known to regulate the expression of several genes involved in TH 
synthesis, such as Tg, TPO, NIS and CtsB, in order to maintain homeostasis of the HPT 
axis. Caraccio et al showed that higher concentrations of TSH lead to higher mRNA 
expression levels of NIS, TPO and Tg, in human thyrocyte cultures [77]. TSH positive 
regulation of NIS expression (the increase of TSH induces the increase of NIS) was also 
confirmed in vivo in rats and humans [78, 79].  
Based on previous reports and on the observed increase in TSH mRNA 
expression levels, it should be expected that an up-regulation would be found in the 
other genes analysed in response to PTU and TCS treatment. A significant increase in 
NIS expression was indeed found for the TCS group, but not for the PTU group (fig 
3.4). This suggests that TCS also influenced the uptake of iodide into thyrocytes, by 
increasing the expression of this transporter, possibly to overcome the reduction of TH 
levels suggested by increased TSH expression and histological analysis. Whether this 
effect of TCS on NIS expression levels is direct or mediated by the change in TSH 
levels is not known, but the fact that no increase in NIS expression was observed for the 
PTU group despite the increase observed in TSH expression levels suggest that the 
effect may be direct. It is also possible that an increase in NIS expression levels 
occurred in the PTU group in an earlier time-frame, and then stabilized to the levels 
measured after 21 days of treatment.     
 
In respect to the relative expression levels for the enzyme TPO, responsible for 
iodide oxidation and iodination of the TH precursor Tg, high variability was found 
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between individuals (especially in the control group) and no significant differences were 
detected between treatment groups (fig 3.4). However, an apparent decrease in both the 
variability and the level of expression was observed in the PTU group and, more 
pronounced, in the TCS group. Although not significant, the suggested decrease in TPO 
expression contrasts with previous studies associating low TPO expression levels with 
the reduction in TSH levels, in human thyrocyte cultures and, in vivo, in normal and 
tumoral human thyroid tissues [77, 80, 81]. Whether the observed differences are due to 
species- or time-course differences is not known and needs to be further explored.  
In addition, the goitrogen PTU is known to produce its anti-thyroidal effects by 
interfering with TPO-mediated iodine utilization in thyroid follicles in mammals. 
Although PTU is used to induce hypothyroidism also in fish [23, 51] no information 
was found about the effects of this goitrogen on the expression of TPO in fish. 
The results obtained in this thesis for the mRNA expression levels of Tg did not 
present significant differences on the gene expression between treatment groups. This 
contrasts with previous studies showing the increase in Tg mRNA expression in 
response to increased TSH concentrations in human thyrocyte cultures, and in rat 
thyroid gland in response to PTU treatment [51, 77]. Nevertheless, an apparent (but not 
statistically significant) increase in Tg mRNA expression was observed in the TCS 
group , which  is caused by two individuals that present an extreme response with a 
great increase in Tg expression (fig 3.4). Clearly it will be important in the future to 
repeat the analysis with samples taken at different time points and also with a greater 
number of samples to conduct a more robust analysis of the effect of TCS on Tg 
expression.  
CtsBa is an isoform of a proteolytic enzyme (CtsB) that, although involved in the 
liberation of THs from Tg, and is not restricted in expression to thyroid tissue [10], 
which could explain its high expression levels obtained for all the groups when 
compared to the other genes analysed. A slight increase in CtsBa mRNA expression 
was observed for the same groups where TSH levels were increased (the PTU and TCS 
groups), but the increase was not statistically significant. These observations are in 
accordance with the detection of increased CtsB mRNA expression in rat thyroid cells, 
in vitro, in response to increased of TSH [82]. However, the relative expression of CtsB 
observed in fig 3.4 reflects the global response of all tissues in the head section, and not 
only from the thyroid tissue. To assess the expression of mRNA encoding for this gene 
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only in the thyroid, further studies are required, by qRT-PCR on smaller sections or by 
localization techniques such as in situ hybridization. 
 
In the present work, different responses were observed for the two compounds 
tested. The response to the (predicted) hypothyroidism induced by PTU did not present 
the characteristic enlargement of the thyroid follicles [73], but caused a decrease in 
thyrocyte height indicative of low thyroid activity. Although the expected increase in 
TSH levels occurred, these were not accompanied by the increase in expression of other 
genes involved in TH synthesis. This situation could be representative of thyroid tissue 
inactivation by PTU in such a way that the high levels of TSH expression could not 
surpass PTU concentration in circulation and maintain hormonal homeostasis. Another 
explanation for the difference between the observations and previously described results 
is that PTU in widely used and studied, in mammals, but almost no information for its 
action is found in fish.  
In the TCS treatment, evidence for hypothyroidism were observed as indicated 
by the characteristic follicle enlargement, reduced thyrocyte height, as well as the 
increase of TSH expression levels. The expression levels of the other analysed genes 
did not present a significant increase with exception to NIS, the iodide pump. The 
increase in NIS expression may be a compensatory mechanism to overcome the 
reduction in circulating THs, regulated by TSH increase. This increases the iodide 
availability for TH synthesis. A similar increase in NIS expression is also observed in 
response to low iodine levels, to increase iodide uptake and compensate for the lower 
serum concentration [10]. 
It has to be taken into to consideration, when analysing the results presented in 
this thesis, that the expression levels determined correspond to only one point in time 
(after 21 days treatment) and that in this point the thyroid system could have reached a 
new equilibrium; also the relative expression levels studied correspond to the 
transcriptome and not to the proteome (protein levels in the tissue), that could show 
different tendencies as proteins are more stable then mRNA and are present for a long 
period of time. In order to further detail the responses involved in the exposure of adult 
zebrafish thyroid tissue, additional experiments using a higher number of individuals 
and studying earlier time points should be performed in the future. 
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Endocrine disruption is caused by compounds that alter normal hormone 
regulation (endocrine disruptors). It has become a major environmental issue as strong 
evidence for the effects in wildlife has become more noticeable. The effects observed 
include development disruption, altered reproductive capacity and abnormal behaviours 
[83]. One of the environments most affected and studied for the actions of endocrine 
disruptors is the aquatic environment, into which more than 100000 different chemicals 
are discharged directly [35]. The effects of the EDs in this environment are more 
pronounced as any lipophilic contaminants present in the water surrounding fish or 
amphibians are readily absorbed, making these animals very susceptible to these 
compounds action. Bioaccumulation effects also need to be taken into consideration as 
most EDs are lipid-soluble and so are concentrated into the fat of the animal [83, 84]. 
Chemicals detected as potential EDs include polychlorinated biphenyls, steroidal 
oestrogens (both natural and synthetic), alkylphenol polyethoxylates (used as 
surfactants), various plasticizers, and a range of herbicides and pesticides. 
Pharmaceuticals discharged in the aquatic environment might also contribute to 
endocrine alterations in the wildlife [83]. Among the pharmaceuticals released into the 
environment, TCS can be found. The widespread use of TCS in PCPs leads to a 
significant presence of this compound in sewage systems in the influent, effluent as well 
as in the sludge produced. Concentrations in the range of 0.01-0.65 µg/l in sewage 
effluent and 0.4-12 µg/g in sludge has been recorded [38-40, 43]. The main source of 
the TCS found in the sewage come from the household products, like cutting boards, 
and PCPs-like toothpaste, mouthwashes, soaps and deodorants [48]. The amount of 
TCS used as a preservative in PCPs is permitted up to concentrations of 0.3% of the 
product. TCS is an antibacterial agent that works by blocking the active site of the 
bacterial enoyl-acyl carrier protein reductase enzyme, essential to fatty acid synthesis 
[85]. Due to its specific bacterial target TCS was though not to have any specific effects 
on higher species. To study the effects of TCS as an endocrine disruptor some studies 
have been performed. Results from the work by Crofton et al in mice demonstrated that 
TCS decreases the levels of T4 in circulation, while Veldhoen et al analysed the effects 
of TCS on tadpoles, indicating the interference of this compound with TH-mediated 
gene expression (thyroid hormone receptors) during metamorphosis [47, 86]. Others 
(Adolfsson-Erici et al) have detected TCS in human breast milk and also in fish [72], 
suggesting the high tendency of this compound to bioaccumulate. On the other hand, the 
work from Canosa et al suggested that food samples might be contaminated by direct 
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contact with TCS-containing kitchenware [87], indicating one other possible route of 
direct exposure in man. 
 
The results of the present study has shown that this compound does in fact 
induce changes on the thyroid tissue physiology of adult zebrafish, evidenced by an 
increased follicle area, decreased thyrocyte height and increased expression of TSH and 
NIS, which suggest that TCS is able to induce hypothyroidism in adult zebrafish. 
Taking into consideration that TCS is released into the environment by sewage 
effluents, it might be expected that wildlife could be strongly affected, due to direct 
exposure, especially affecting fish and amphibian, or indirectly, as TCS bioaccumulates 
in the organism. Exposure of humans due to the direct (cumulative) exposure to very 
low amounts of this compound and the ingestion of animals in which the compound has 
bioaccumulated must also be taking into consideration, and further studies should be 
performed to evaluate its actions in the human thyroid physiology.  
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5. Conclusion 
 
This study investigated the effects of adult zebra fish exposure to the compound 
TCS. Histological observations allowed the direct visualisation of some of the effects: 
evidence of thyroid follicle proliferation and inactive follicles, which appeared as large 
follicles completely filled with colloid and limited by a thin epithelial layer.  
Also by histological analysis, it was possible to verify that the PTU group which 
served as a treatment control as it reduces thyroid tissue activity, also presented 
evidence of inactive follicles (verified by the thyrocyte height). This indicates that the 
concentration of PTU applied is appropriate to induce hypothyroidism in adult zebra 
fish. 
Molecular techniques were used as an approach to understand how the drugs 
acted on the gene expression of key proteins involved in TH synthesis, in zebra fish 
heads. Using qRT-PCR, it was observed that 18S rRNA could not be used as a reference 
gene and instead GADPH-2 was validated as reference gene for the zebra fish collected 
from the experiments, as this gene presented no variation between the PTU, TCS or 
control groups. Following normalization of qRT-PCR results, the relative expression of 
the target genes analysed indicated that only TSH was significantly affected by the PTU 
treatment, showing an increase in expression, while relative expression of TSH and NIS 
were significant increased in zebra fish treated with TCS. 
In face of these results it can be concluded that the antimicrobial agent TCS at 
the dose used in the present study 100 mg/Kg/day appears to have a direct effect on 
diverse genes the protein products of which influence THs synthesis in adult zebra fish. 
Although these results are highly indicative of the effects of exposure to TCS, 
further work could be performed as complement. Among the possibilities of analysis 
which would enrich the current analysis are: 
- imunohistochemistry of some of the studied proteins to localize the expression 
and to confirm the effects at the protein level; 
- analysis of gene expression at several points in time, during the 21 days, to 
observe the change in effect of treatment with time; 
- analysis of the response of exposure to lower concentrations of TCS and also 
the response to the removal of the goitrogen from the environment after a previous 
exposure; 
- measuring THs levels by the end of the treatment. 
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Annex 1: Solutions 
 
 
Loading Buffer 
Prepare a solution of 40% glucose in sterile water (40 g glucose in 100 mL). When the 
glucose is dissolved, just a sprinkle of Bromophenol blue was added to give the colour 
to the sample. This was made tanking into consideration that only a small amount of 
bromophenol blue is needed, otherwise the solution would turn very blue. 
Once all the components were dissolved, the solution was filter sterilise with a syringe 
coupled to an adapter filter of 0.2 µm. The solution was stored in a new falcon tube. 
 
 
DEPC water 
For 2 litters: 
A dark glass bottle was filled with 2L of distilled water, to which were added 200 µL of 
Diethyl Pyrocarbonate – DEPC (100 µL of DEPC per litter of water) 
The mixture was agitated and left to rest for 24 hours. The solution was autoclaved.  
 
10X OPA buffer 
(100 mM Tris-acetate pH 7.5 / 100 mM Magnesium-acetate / 500 mM potassium 
acetate) 
 
To prepare 10 mL 
 
Add 500 µL of TAE 50x 
Weigh 0.2 g MgAc 
Weigh 0.5 g KAc 
Complete the volume to 10 mL with sterile distilled water. Agitate and dissolve the 
solids. 
Make aliquots of 100 µL and store at -20 ºC. 
 
 
 
 
 B 
LB (Luria-Bertani) Broth  
Dissolve 4 LB broth tablets (Sigma) in 200 mL of distilled water, autoclave and 
store at room temperature. 
 
- LB agar 
Dissolve 8 LB agar tablets (Sigma) in 400 mL of distilled water, autoclave and 
allow to cool to 55 ºC in a water bath and pour into Petri dishes. This step should be 
performed in the laminar flow cabinet. In alternative store the bottle after 
autoclaving and melt in the microwave when needed, allow to cool to 55 ºC and 
pour into Petri dishes. 
 
- LB selective plates 
After melting the LB agar and allowing to cool to 55 ºC, add antibiotic or X-Gal 
to the desired concentration as presented on table A1 before pouring into Petri 
dishes. This step should be performed in the laminar flow cabinet. Store the plates in 
the fridge for at least 2-3 h before use. 
 
Table A 1: Antibiotic and solutions concentrations for the LB selective plates 
Antibiotic/solution Used at 
Ampicilin 75 µg/mL 
IPTG 0.5 mM 
X-GAL 80 µg/mL 
 
Stock IPTG (0,5M) 
 
Dissolve the IPTG in water until achieve the desired concentration (0,5M) 
Aliquot and store at -20ºC 
 
 
Solutions for the alkaline lysis 
 
- GTE buffer  
For 500mL: 
Add 4.505 g glucose, 12.5 mL TRIS-HCl 1 M (pH = 7.5) and 10 mL EDTA 0.5 M. 
Complete the volume with distilled water. Mix well and autoclave. 
 
 C 
- NaOH 0,2 M/SDS 1% 
 
For a volume of 14 mL: 
Add 560µL NaOH 5M, 700 µL SDS 20% and 12.74 mL sterile water to complete 
the volume.  
 
- Potassium Acetate (KAc) 
 
• KAc 5M stock (for 200 mL): 
Dissolve 98.14 g of potassium acetate in 200 mL of distilled water, 
autoclave and store at room temperature. 
 
• KAc for alkaline lysis (3M in potassium, 5M in acetate) for 100 mL: 
Mix 60 mL of KAc 5M stock with 11.5 mL glacial acetic acid. The pH was 
checked, to verify if it fits between 4.8 and 5.2. If not, pH was adjusted by 
adding more glacial acetic acid. The final volume was adjusted with distilled 
water and the solution was stored at room temperature. 
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Annex 2: APES treatment of slides 
 
 
APES coating of slides is an alternative method that makes the slides more 
adhesive for fixed tissues and living cells. 
 
The slides were loaded onto big slide racks, and each rack was immersed for 30 
min in 1% acid/alcohol (1% v/v concentrated HCl, 70% ethanol, 29% water) thus 
allowing to clean the slides. After the immersion in 1% acid/alcohol the slides were 
rinsed in running tap water, followed by immersion in distilled water. The slides were 
allowed to dry ON at room temperature. 
  The racks with the slides were immersed for 10 min in acetone, followed by a 
5 min immersion in 2% (v/v) APES in acetone. The slides were immersed briefly in 2 
sequential rinses of distilled water and allowed to dry. Once dried, the slides were 
removed from the racks and stored in a dust-free container. 
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Annex 3: Competent bacteria 
 
To obtain competent bacteria cells, one colony of the strain Escherichia coli XL-1 Blue, 
was isolated from a plate of LB medium (30 mg/ml tetracycline) and used to inoculate 5 
ml of LB medium. Cells were incubated for 12-16 h at 30ºC and 250 rpm. 
 1 ml of the culture was inoculated in 250 ml of SOB medium and incubated 
with agitation at 18ºC until a DO of 0.6 nm was reached. The bacterial suspension was 
incubated on ice to stop growth for 10 min and transferred to 50 ml Falcon tubes and 
centrifuged 1200 g, 10 min, 4ºC. The supernatant was discarded and the pellet 
ressuspended in 16 ml of cold transformation buffer (TB), a rich solution of CaCl2, 
incubated on ice for additional 10 min and centrifuged as described above. DMSO 
(cryo-preserving agent) was added until a final concentration of 7% was reached and 
bacteria were incubated for 10 min and aliquoted in 100 µl samples and immediately 
frozen in liquid nitrogen and stored at -80ºC until further use. 
 
SOB médium (250 mL): 
2% Bacto tryptone (5g); 
1.5% yeast extract (1.25g); 
10 mM NaCl (500 µL stock 5M); 
2,5 mM KCl (625 µL stock 1M); 
10 mM MgCl2 (2.5 mL stock 1M); 
10 mM MgSO4 (2.5 mL stock 1M); 
Autoclave after prepare. 
 
TB buffer (100 mL): 
10 mM Pipes (0.30 g); 
15 mM CaCl2 (1.5 mL stock 1M); 
250 mM KCl (25 mL stock 1M); 
Adjust pH to 6.7 with KOH 1M, other wise the pipes will not dissolve (take in 
consideration that the pH changes very fast when near the optimum). After is fully 
dissolved and the pH is at 6.7 add 55mM MnCl2 (0.69 g). Filter with 0.22 µm filter to 
sterilize. Do not autoclave the solution. Store it at 4 ºC until use. 
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Annex 4: pGEM-Teasy restriction map 
 
pGEM-T Easy vector 
 
 
 
 
 
 
Figure A 1: pGEM -T Easy vector map and reference points. 
 
 
 
 
 
 
 
Figure A 2: The promoter and multiple cloning sequence of the pGEM®-T Easy Vector. The top strand 
of the sequence shown corresponds to the RNA synthesized by T7 RNA polymerase. The bottom strand 
corresponds to the RNA synthesized by SP6 RNA polymerase. 
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Annex 5: NIS alignment 
 
Figure A 3: NIS sequence alignments of the sequences from the database (NIS__datab), the sequence from the cloned fragment (NIS__seque) 
with the cloning primer sequence (green) and the qRT-PCR amplicon sequence (NIS_RT) with the primer sequence (yellow). 
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Annex 6: TSH alignment  
 
Figure A 4: TSH sequence alignments of the sequences from the database (TSH__datab), the sequence from the cloned fragment (TSH__seque) 
with the cloning primer sequence (green) and the qRT-PCR amplicon sequence (TSH_RT) with the primer sequence (yellow). 
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Annex 7: TPO alignment 
 
 J
 
 
Figure A 5: TPO sequence alignments of the sequences from the database (TPO__datab), the sequence from the cloned fragment (TPO__clon) 
with the cloning primer sequence (green) and the qRT-PCR amplicon sequence (TPO_RT) with the primer sequence (yellow). 
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Annex 8: Tg alignment 
 
Figure A 6: Tg sequence alignments of the sequences from the database (Tg__datab), the sequence from the cloned fragment (Tg__sequen) with 
the cloning primer sequence (green) and the qRT-PCR amplicon sequence (TPO_RT) with the primer sequence (yellow). 
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Annex 9: CtsBa alignment 
 
Figure A 7: CtsBa sequence alignments of the sequences from the database (CtsBa__datab), the sequence from the cloned fragment (CtsBa_clon) 
with the cloning primer sequence (green) and the qRT-PCR amplicon sequence (CtsBa_RT) with the primer sequence (yellow). 
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Annex 10: GADPH-2 alignment 
 
Figure A 8: GADPH-2 sequence alignments of the sequences from the database (GADPH-2_da), the sequence from the cloned fragment 
(GADPH-2) with the cloning primer sequence (green) and the qRT-PCR amplicon sequence (GADPH-2_RT) with the primer sequence (yellow). 
